Medical School of Debrecen - University of South Florida- Dr Andor Szentivanyi

In Memory of:

Andor Szentivanyi, M.D., D.Sc,
University distinguished Professor of Medicine,
University of South Florida, Tampa Florida, USA. 
Co-editor-in-chief of the book series: Neuroimmune Biology

1926 - 2005

BORN: Born in Miskolc, Hungary, in 1926

DIED: Oct. 22, 2005, in Tampa, Florida, U.S.A.

SURVIVORS: His wife of 56 years, Judith, of Lutz; sons Peter and Edward Saint-Ivan of Lutz

SERVICES: Buried Sunday Oct. 23, 2005 at Gan Shalom Cemetery, Tampa Florida. USA. 

Dr Andor Szentivanyi

Dr Andor Szentivanyi

 

Dr.Andor Szentivanyi was born in Miskolc Hungary in 1926. He  died Oct. 2 at the age of 79 in Tampa Florida. U.S.A. He has received numerous awards for his hard work and many contributions to the advancement of medical sciences throughout his career. He graduated from the Medical School of Debrecen and served as a resident physician in Hungry before he emigrated to the United States in 1957.,

Once in the U.S.A., he was awarded a Rockefeller Fellowship at the University of Chicago. He held academic appointments in Internal Medicine, Pharmacology and Microbiology at the University of Chicago, the University of Colorado and Creighton University in Omaha, NE. He was well known for his theories in understanding allergic diseases.

University of South Florida 
University of South Florida 
Health Sciences Center

In 1970, Dr. Szentivanyi joined the University of South Florida College of Medicine as chairperson of the Department of Pharmacology and Therapeutics. He was dean of the College of Medicine from 1980 to 1986 during which time some of the college’s major affiliations were expanded and established, including those with Shriners Children’s Hospital, the H.Lee Moffitt Cancer and Research Institute and the USF Psychiatry Center. During this time Tampa General Hospital tripled in size, an expansion that was only possible through a connection with USF. While dean, he recruited faculty and world renowned researchers to USF, including pediatrician and immunologist Robert A. Good, DSc, PhD, MD, and immunologist Louis Chedid, MD. After his resignation as Dean of USF in 1987 Dr. Szentivanyi returned to full-time teaching and research and continued to garner recognition.

Among the honors he has received are the USF Outstanding Teacher Award, the USF College of Medicine Distinguished Scientist Award, an honorary M.D. from the University of Saarland in West Germany and a commendation medal from the Florida Heart Association.

He has received The Founder Award, one of the highest honors from the University of South Florida which recognizes substantial and sustained contributions to the development of the College of Medicine and the Health Sciences Center.

In 1988, he was named a USF Distinguished Research Professor. He was one of the eight premier researchers listed in Milestones in Allergy, which brought together articles that framed the science of allergy. His work, titled “The Beta Adrenergic Theory of Atopic Abnormality in Bronchial Asthma” was first published in the Journal of Allergy in 1968 and introduced a concept that the body’s abnormal response to an allergen and resulting airway constriction was due to a defect in biochemical response mechanisms. The work led to the development of new approaches to asthma treatment. In 1994, he was honored for his science and humanity when he was awarded the Donn L. and Ruth E. Smith Founder Award one of the highest honors from the University of South Florida which recognizes substantial and sustained contributions to the development of the College of Medicine and the Health Sciences Center.

Dr. Szentivanyi's research interests included the study and treatment of bronchial asthma, and the role of the body's neurological system and the immune response mechanism. He has written or edited several books, one of which is   "The Immunologic Revolution," a collection of historical essays edited by Dr.Szentivanyi and Herman Friedman, Ph.D., chairperson of the Department of Medical Microbiology and Immunology.

Neuroimmune Biology

He was the co-editor of the Book Series Neuroimmune Biology and is further honored in Volume 6 of this Series by Dr Istvan Berczi.

(Neuroimmune Biology Volume 6, 2006)

Andor Szentivanyi  (1926-2005)

Fifty six years ago Andor Szentivanyi and colleagues were the first to document with exact scientific methodology in animal experiments that the nervous system has a sweeping regulatory power over immune reactions. At that time Szentivanyi was a resident at the Medical School of Debrecen in Hungry, when he observed that adrenaline was ineffective to inhibit an asthmatic attack in a patient. This clinical observation inspired him and his colleagues to do animal experiments using anaphylactic shock as a model system. In these experiments it was observed that hypothalamic lesions inhibited the development of anaphylactic shock in immunized animals [1]. Hypothalamic tuberal cinereum lesions (TBL) inhibited anaphylaxis in pre-immunized guinea pigs and in later experiments also in rabbits. Anaphylaxis was elicited in immunized animals by the intravenous injection of the immunizing antigen. Antibody production was also inhibited if TBL was done prior to immunization. Such lesions did not affect the reaction of antibodies with the specific antigen, nor did the release of tissue materials mediating anaphylaxis. Hypothalamic lesions temporarily increased the resistance of the animals to histamine and inhibited the anaphylactic reaction even when the animals were provided with passively transferred antibodies, which elicited lethal shock in control animals. The Schultz-dale test, which was performed with small pieces of intestine in vitro, was also inhibited by TBL. The Arthus reaction, turpentine induced inflammation and the Sanarelli-Schwartzmann phenomenon were unaffected. Lesions of other areas of the hypothalamus or of the central nervous system were ineffective in modulating immune phenomena. Furthermore, electrical stimulation of the mammillary region of the hypothalamus had an inhibitory effect on the anaphylactic response and increased the resistance of animals to histamine [2-4]. In 1964 Korneva and Khai [5] confirmed that hypothalamic lesions in rabbits, guinea pigs and rats inhibited the production of complement fixing antibodies.

Szentivanyi devoted his entire career of 56 years to research on the pathomechanisms of allergy and asthma. His animal experiments pointed to the importance of the beta adrenergic receptor (bADR) in anaphylactic reactions [6]. In 1968 Szentivanyi had synthesized the contemporary knowledge and all his findings in a review article [7]. He concluded that bronchial asthma, whether it is due to ‘extrinsic’ or ‘intrinsic’ causes, is ultimately elicited by the same mediators, such as histamine, serotonin, catecholamines, slow reactive substances plus cytokines. These are released during asthmatic reactions and should be considered as an additional group of mediators in many tissues and in most species. Glucocorticoids are natural inhibitors of inflammation. He proposed that the fundamental mechanism underlying the atopic abnormality in asthma is the abnormal function of the beta-adrenergic system, irrespective of what triggered the reaction. 

He concludes: The beta adrenergic theory regards asthma not as an ‘immunological disease, but as a unique pattern of bronchial hypersensitivity to a broad spectrum of immunological, psychic, infectious, chemical and physical stimuli. This gives to the antigen-antibody interaction the same role as that of a broad category of non-specific stimuli, which function only to trigger the same defective homeostatic mechanism in the various specialized cells of bronchial tissue” [7].

This article became a citation classic and has been published again as a classical article of lasting value in "Milestones in Allergy," L Berrens, ed., Mosby/Doyma Libros, Barcelona, Spain, in 1995 [8]. Indeed this paper has popularized the dominant role of the central nervous system in inflammatory diseases and of the importance of multi-disciplinary approaches for the understanding of such diseases.

Szentivanyi remained faithful to the idea of beta-adrenergic malfunction in atopy and asthma for his entire scientific career. This was the common thread that connected the numerous papers, reviews, book chapters and books he published. He studied alpha and beta-adrenergic receptors; adenylate cyclase, cyclic-AMP and signal transduction; isolated, characterized and pharmacologically modulated phosphodiesterase; observed the systemic effect of immunization and of endotoxin on the adrenergic and cholinergic systems, on metabolism and on immune inflammatory mediators; performed clinical studies on asthma and related conditions. His major observations are:

1.      Beta-adrenergic sub-sensitivity exists in patients with atopic dermatitis who never received adrenergic medication. This indicates that therapeutic desensitization cannot account for the dysfunction of the beta-adrenergic system [9].

2.      The beta-adrenergic reactivity of lung tissue of lymphocytes and bronchocytes from patients with atopic asthma was found to be abnormal and various patterns of drug vs. disease-induced sub-sensitivity could be recognized [10-15].

3.      Bronchial hyper-reactivity to cholinergic agents in asthma was not mediated through cholinergic mechanisms but it was caused by the adrenergic abnormality, which was due to the so called “denervation super-sensitivity” [16-19].

4.       Lymphocytes of asthmatic patients showed a significant decrease in adrenaline binding to beta-adrenergic receptors, which was independent of therapy [11,12,15].

Szentivanyi also studied the effects of inflammation on beta-adrenergic receptors. He studied glucocorticoid (GC) action in disease and regarded GC as important inhibitory hormones [20-24]. The pro-inflammatory cytokine, IL-1alpha (IL-1a) was found to bind to human bronchial epithelial cells and induced the production of beta adrenoreceptor mRNA [25]. Beta adrenoreceptor had an upregulatory effect on IL-1a secretion by lymphocytes in vitro, which showed cell and species specificity [26]. It was discovered that IgE and beta adrenergic stimulation interacted in the regulation of cyclic AMP concentrations in A549 human pulmonary epithelial cells [27]. IgE decreases endothelin-1 production in A549 cells [28]

Szentivanyi’s work and ideas were a major source of inspiration for me. In 1992 the World Congress of Immunology was held in Budapest and I was invited to organize a satellite symposium on Psychoneuroimmunology. I organized this meeting with Judit Szelenyi  in Budapest and we invited Szentivanyi as a Guest of Honor to deliver the keynote lecture to the symposium [29]. This was the beginning of our collaboration and friendship, which intensified over the years [30]. In 2000 we have initiated the book series, entitled Neuroimmune Biology, and worked together on 9 volumes till his passing away [31-66]. He was to write a Preface to volume 9 as yet, but this commitment could not be fulfilled. He was very proud of Neuroimmmune Biology and anticipated a bright future for these books.

Szentivanyi lists nearly 500 publications and 29 books to his credit. Throughout his lifetime he received numerous awards and distinctions and has been advisor/consultant to many scientific and public organizations. He was one of the founders of the Faculty of Medicine at the University of South Florida and built and organized many departments and Institutions associated with this School. He served this University with full devotion for over 35 years.

Andor was a humanist, a pacifist, a tireless champion of the poor and disadvantaged; he fought against social and political injustice, and was always ready to take risks and sacrifices for his principles. His passing is a great loss to modern biomedical science, and indeed, to mankind as well.

                                                                                                                        Istvan Berczi

REFERENCES

1. Filipp G, Szentivanyi A, Mess B. Anaphylaxis and nervous system. Acta Med Hung 1952; 2: 163-73.
2. Szentivanyi A, Filipp G. Anaphylaxis and the nervous system. Part II. Ann Allergy 1958; 16: 143-151.
3. Filipp G, Szentivanyi A. Anaphylaxis and the nervous system. Part III. Allergy 1958; 16: 306-11.
4. Szentivanyi A, Szekely J. Effect of injury to, and electrical stimulation of, hypothalamic areas on anaphylactic    and histamine shock of the guinea pig. A preliminary report. Ann Allergy 1956; 14: 259-261.
5. Korneva EA, Khai LM.Effect of destruction of hypothalamic areas on immunogenesis. Fed Proc 1964; 23: T88.
6. Townley RG, Trapani IL, Szentivanyi A. Sensitization to anaphylaxis and to some of its pharmacological mediators by blockade of the beta adrenergic receptors. J Allergy 1967; 39(3): 177-79.
7. Szentivanyi A. The beta adrenergic theory of the atopic abnormality in bronchial asthma. J. Allergy 1968; 42: 203-32.
8. Szentivanyi, A: The beta-adrenergic theory of the atopic abnormality in bronchial asthma. Reprinted In:"Milestones in Allergy," L Berrens, ed., Mosby/Doyma Libros, Barcelona, Spain, 1995, pp. 69-102.
9. Szentivanyi A, Szentivanyi J, Wagner H. Measurement of numbers of adrenoceptors in lymphocytes and lung tissue of patients with reversible obstructive airways disease. Clin Pharmacol Ther 1980; 27: 193-206.
10. Szentivanyi A. The conformational flexibility of adrenoceptors and the constitutional basis of atopy. Triangle 1979; 18(4): 109-15.
11. Szentivanyi A, Heim O, Schultze P.Changes in adrenoceptor densities in membranes of lung tissue and lymphocytes from patients with atopic disease. Ann NY Acad Sci. 1979; 332: 295-298.
12. Szentivanyi A.   La flexibilite de conformation des adrenocepteurs et la base constitutionelle du terrain allergique. Rev Franc Allergol 1979; 19: 205-214.
13. Szentivanyi A, Fitzpatrick DF. The altered reactivity of the effector cells to antigenic and pharmacological influences and its relation to cyclic nucleotides. II. Effector reactivities in the efferent loop of the immune response. In:  Filipp G, editor.  Pathomechanismmus und Pathogenese Allergischer Reaktionen. Werk-Verlag Dr. Edmund Banachewski, Grafelfing bei Munchen 1980: 511-580.
14. Szentivanyi A, Polson JB, Krzanowski JJ. The altered reactivity of the effector cells to antigenic and pharmacological influences and its relation to cyclic nucleotides. I. Effector reactivities in the efferent loop of the immune response. In: Filipp G, editor.  Pathomechanismus und Pathogenese Allergischer Reaktionen. Werk-Verlag, Dr. Edmund Banachewski, Grafelfing bei Munchen 1980: 460-510.
15. Szentivanyi A, Krzanowski JJ, Polson JB, Anderson WH.  Evolution of research strategy in the experimental analysis of the beta adrenergic approach to the constitutional basis of atopy.  In: Oehling A, Mathov E, Glazer I, Arbesman C, editors. Advances in Allergology and Clinical Immunology.  Oxford, Pergamon Press, 1980: 301-308.
16. Szentivanyi A. Effect of bacterial products and adrenergic blocking agents on allergic reactions.  In: Samter M, Talmage DW, Rose B, Sherman WB, Vaughan JH, editors.  Textbook of Immunological Diseases.  Boston, MA:  Little, Brown and Co.1971: 356-374.
17. Szentivanyi A, Krzanowski JJ, Polson JB. The autonomic nervous system: Structure, function, and altered effector responses.  In: Middleton E, Reed CE, Ellis EF, editors. Allergy: Principles and Practice. St. Louis, MO, The CV Mosby Co, 1978:  256-300.
18. Szentivanyi A, Williams JF. The constitutional basis of atopic disease. In: Bierman CW, Pearlman DS, editors. Allergic Diseases of Infancy, Childhood, and Adolescence. Philadelphia, PA, WB Saunders Co1980: 173-210.
19. Szentivanyi A. Adrenergic and cholinergic receptor studies in human lung and lymphocytic membranes and their relation to bronchial hyperreactivity in asthma.  In:  Patient Care Publications.  Darien, CT , 1982:  175-92..
20. Hackney JF, Szentivanyi A. The specificity of glucocorticoids in the relaxation of respiratory smooth muscle in vitro.  J Allergy Clin Immunol 1975; 55:123 (abstract).
21. Hackney JF, Szentivanyi A. The unique action of glucocorticoid succinates on respiratory smooth muscle in vitro. The Pharmacologist  1975; 17: 271. (abstract).
22. Lowitt S, Szentivanyi A, Williams JF.  Endotoxin inhibition of dexamethasone induction of tryptophan oxygenase in suspension culture of isolated rat parenchymal cells. II. Effect of in vivo pretreatment of rats with endotoxin. Biochem Pharmacol 1982; 31: 3403-3406.
23. Szentivanyi A, Szentivanyi J. Mechanisms of action of corticosteroids.  In: Proceedings of the International Symposium on Allergy and Immunology.  Lima, Peru, 1985: 531-534.
24. Szentivanyi A, Szentivanyi J. Mechanisms of action of corticosteroids.  In: Proceedings of the International Symposium on Allergy and Immunoloty.  Lima, Peru, 1985: 227-241.
25. Robicsek, S, Szentivanyi, A, Calderón, EG, Heim, O, Schultze, P, Wagner, H, Lockey, RF, and Dwornik, JJ:  Concentrated IL-1a derived from human T-lymphocytes binds to a specific single class surface receptor on human bronchial epithelial cells and induces the production of beta-adrenocep tor mRNA via an associated or separate receptor-linked signalling pathway.  J. Allergy Clin. Immunol. 89:212, 1992.
26. Szentivanyi, A, Calderón, EG, Heim, O, Schultze, P, Wagner, H, Zority, J, Lockey, RF, Dwornik, JJ, and Robicsek, S:  Cell- and species-specific dissociation in the beta-adrenoceptor upregulating effects of IL-1a derived from lymphocyte conditioned medium and cortisol.  J. Allergy Clin. Immunol. 89:274, 1992.
27. Szentivanyi, A, Ali, K, Calderón, EG, Brooks, SM, Coffey, RG, and Lockey, RF.  The in vitro effect of immunoglobulin E (IgE) on cyclic AMP concentrations in A549 human pulmonary epithelial cells with or without beta-adrenergic stimulation.  J. Allergy Clin. Immunol. 91:379, 1993.
28. Stewart, GE, Calderón, E, Szentivanyi, A, and Lockey, RF:  IgE decreases endothelin-1 production in A549 pulmonary epithelial cells.  J. Allergy Clin. Immunol. 93:244, 1994.
29. Szentivanyi, A and Abarca, C:  The Immune-Neuroendocrine Circuitry - The Next, and Possibly, the Last Frontier of Vertebrate Immunity.  In: "Advances in Psychoneuroimmunology," Vol. 3, I Berczi and J Szelényi, eds., Plenum Press, New York, 1994, pp. 41-74.
30. Berczi, I and Szentivanyi, A:  The pituitary gland, psychoneuroimmunology and infection. In:  "Psychoneuroimmunology, Stress, and Infection," H Friedman, TW Klein, and A Friedman, eds., CRC Press, Boca Raton, FL, 1996, pp. 71-98.
31. Berczi I, Szentivanyi A, Series editors, Berczi I, Gorczynski R, Editors: Neuroimmune Biology Volume 1; New Foundation of Biology. Elsevier, Amsterdam, 2001.
32. Berczi I, Szentivanyi A. Why Neuroimmune Biolory? Editorial. In “Neuroimmune Biology Volume 1: New foundation of Biology” Berczi I, Gorczynski R, Editors, Elsevier, 2001;pp. vii-xii
33. Szentivanyi A, Berczi I, Pitak D, Goldman A. Studies of the hypothalamic regulation of histamine synthesis. In “Neuroimmune Biology Volume 1: New foundation of Biology” I. Berczi I, Gorczynski R, Editors, Elsevier, 2001; pp. 47-55
34. Berczi I, Szentivanyi A, Series Editors, Matera L, Rapaport R, Editors, Neuroimmune Biology Volume 2: Growth and Lactogenic Hormones. Elsevier, Amsterdam, 2002.
35. Berczi I. Szentivanyi A. Series Editors and Editors, Neuroimmmune Biology, Volume 3: The Immune-Neuroendocrine Circuitry. History and Progress. Elsevier, Amsterdam, 2003.
36. Berczi I. Szentivanyi A. Foreword. In “Neuroimmmune Biology, Volume 3: The Immune-Neuroendocrine Circuitry. History and Progress. Berczi I, Szentivanyi A, Editors, Elsevier, Amsterdam, 2003; p. v.
37 Berczi I. Szentivanyi A. Preface. In “Neuroimmmune Biology, Volume 3: The Immune-Neuroendocrine Circuitry. History and Progress. Berczi I, Szentivanyi A, Editors, Elsevier, Amsterdam, 2003; pp. vii-viii.
38. Szentivanyi A, Berczi I, Nyanteh H, Goldman A. Introduction. In “Neuroimmmune Biology, Volume 3: The Immune-Neuroendocrine Circuitry. History and Progress. Berczi I, Szentivanyi A, Editors, Elsevier, Amsterdam, 2003; p.5.
39. Szentivanyi A, Berczi I, Nyanteh H, Goldman A. history. In “Neuroimmmune Biology, Volume 3: The Immune-Neuroendocrine Circuitry. History and Progress. Berczi I, Szentivanyi A, Editors, Elsevier, Amsterdam, 2003; pp.7-14.
40. Szentivanyi A, Berczi I, Nyanteh H, Goldman A. The discovery of immune neuroendocrine circuitry - A generation of progress. In “Neuroimmmune Biology, Volume 3: The Immune-Neuroendocrine Circuitry. History and Progress. Berczi I, Szentivanyi A, Editors, Elsevier, Amsterdam, 2003; pp. 15-18.
41. Szentivanyi A, Berczi I, Nyanteh H, Goldman A. Altered effector responses. In “Neuroimmmune Biology, Volume 3: The Immune-Neuroendocrine Circuitry. History and Progress. Berczi I, Szentivanyi A, Editors, Elsevier, Amsterdam, 2003; pp. 21-29.
42. Szentivanyi A, Berczi I, Nyanteh H, Goldman A. Some evolutionary morphoregulatory and functinal aspects of the immune-neuroendocrine circuitry. In “Neuroimmmune Biology, Volume 3: The Immune-Neuroendocrine Circuitry. History and Progress. Berczi I, Szentivanyi A, Editors, Elsevier, Amsterdam, 2003; pp. 31-61.
43. Szentivanyi A, Berczi I, Nyanteh H, Goldman A. Virus associated immune and pharmacologic mechanisms in disorders of respiratory and cutaneous atopy. In “Neuroimmmune Biology, Volume 3: The Immune-Neuroendocrine Circuitry. History and Progress. Berczi I, Szentivanyi A, Editors, Elsevier, Amsterdam, 2003; pp. 63-95.
44. Berczi I, Szentivanyi A. Adhesion molecules. In “Neuroimmmune Biology, Volume 3: The Immune-Neuroendocrine Circuitry. History and Progress. Berczi I, Szentivanyi A, Editors, Elsevier, Amsterdam, 2003; pp. 99-115.
45. Berczi I, Szentivanyi A. Immunoglobulins. In “Neuroimmmune Biology, Volume 3: The Immune-Neuroendocrine Circuitry. History and Progress. Berczi I, Szentivanyi A, Editors, Elsevier, Amsterdam, 2003; pp. 117-127.
46. Berczi I, Szentivanyi A. Growth and lactogenic hormones, insulin-like growth factor and insulin. In “Neuroimmmune Biology, Volume 3: The Immune-Neuroendocrine Circuitry. History and Progress. Berczi I, Szentivanyi A, Editors, Elsevier, Amsterdam, 2003; pp. 129-153.
47. Berczi I, Szentivanyi A. The hypothalamus-pituitary-adrenal axis and opioid peptides. In “Neuroimmmune Biology”, Volume 3: The Immune-Neuroendocrine Circuitry. History and Progress. Berczi I, Szentivanyi A, Editors, Elsevier, Amsterdam, 2003; pp. 155-174.
48. Berczi I, Szentivanyi A. The hypothalamus-pituitary-thyroid axis. In “Neuroimmmune Biology, Volume 3: The Immune-Neuroendocrine Circuitry. History and Progress. Berczi I, Szentivanyi A, Editors, Elsevier, Amsterdam, 2003; pp 175-180.
49. Berczi I, Szentivanyi A. Nerve growth factror, leptin and neuropeptides. In “Neuroimmmune Biology, Volume 3: The Immune-Neuroendocrine Circuitry. History and Progress. Berczi I, Szentivanyi A, Editors, Elsevier, Amsterdam, 2003; pp. 181-189.
50. Berczi I, Szentivanyi A. Cytokines and chemokines. In “Neuroimmmune Biology, Volume 3: The Immune-Neuroendocrine Circuitry. History and Progress. Berczi I, Szentivanyi A, Editors, Elsevier, Amsterdam, 2003; pp. 191-220.
51. Berczi I, Nagy E, Baral E, Szentivanyi, A. Sterid Hormones. In “Neuroimmmune Biology, Volume 3: The Immune-Neuroendocrine Circuitry. History and Progress”. Berczi I, Szentivanyi A, Editors, Elsevier, Amsterdam, 2003; pp. 221-270.
52. Berczi I, Szentivanyi A. Immunocompetence. In Neuroimmmune Biology, Volume 3: The Immune-Neuroendocrine Circuitry. History and Progress. Berczi I, Szentivanyi A, Editors, Elsevier, Amsterdam, 2003; pp. 281-299.
53. Berczi I, Szentivanyi A. Antigen presentation. In Neuroimmmune Biology, Volume 3: The Immune-Neuroendocrine Circuitry. History and Progress. Berczi I, Szentivanyi A, Editors, Elsevier, Amsterdam, 2003;pp. 301-313.
54. Berczi I, Szentivanyi A. Immune reactions. In Neuroimmmune Biology, Volume 3: The Immune-Neuroendocrine Circuitry. History and Progress. Berczi I, Szentivanyi A, Editors, Elsevier, Amsterdam, 2003; pp. 315-377.
55. Berczi I, Szentivanyi A. The acute phase response. In Neuroimmmune Biology, Volume 3: The Immune-Neuroendocrine Circuitry. History and Progress. Berczi I, Szentivanyi A, Editors, Elsevier, Amsterdam, 2003; pp. 463-494.
56. Berczi I, Szentivanyi A. Autoimmune disease. In Neuroimmmune Biology, Volume 3: The Immune-Neuroendocrine Circuitry. History and Progress. Berczi I, Szentivanyi A, Editors, Elsevier, Amsterdam, 2003; pp.495-536.
57. Berczi I, Szentivanyi A. Immunodeficiency. In Neuroimmmune Biology, Volume 3: The Immune-Neuroendocrine Circuitry. History and Progress. Berczi I, Szentivanyi A, Editors, Elsevier, Amsterdam, 2003; pp.537-558.
58. Berczi I, Szentivanyi A. The immune-neuroendocrine circuitry. In Neuroimmmune Biology, Volume 3: The Immune-Neuroendocrine Circuitry. History and Progress. Berczi I, Szentivanyi A, Editors, Elsevier, Amsterdam, 2003; pp. 561-592.
59. Berczi I, Szentivanyi A, Series editors, Straub RH, Mocchegiani E. Editors: Neuroimmune Biology Volume 4; The Neuroendocrine Immune Network in Ageing. Elsevier, Amsterdam, 2004.
60. Berczi I, Szentivanyi A. Concluding remarks and future directions. In The Neuroendocrine Immune Network in Ageing. Straub RH, Mocchegiani E. Editors, Neuroimmune Biology Volume 4. Berczi I, Szentivanyi A, Series editors. Elsevier, Amsterdam, 2004. Pp. 409-427
61. Bertok L, Chow DA. Eds. Natural Immunity. Neuroimmune Biology Volume 5. Berczi I, Szentivanyi A, Series editors. Elsevier, Amsterdam, 2005.
62. Berczi I, Szentivanyi A. Foreword. In Cytokines and the Brain. Phelps C, Korneva E. Editors, Neuroimmuine Biology, Volume 6. Berczi I, Szentivanyi A. Series editors. Elsevier, Amsterdam, 2006. (submitted).
63. Berczi I. Szentivanyi A. Preface. In The Hypothalamus-Pituitary-Adrenal Axis. DelRey A, Chrousos G, Besedovsky H. Editors, Neuroimmune Biology, Volume 7. Berczi I, Szentivanyi A. Series editors. Elsevier, Amsterdam, 2006. (submitted)
64. DelRey A, Chrousos G, Besedovsky H. Editors, The Hypothalamus-Pituitary-Adrenal Axis. Neuroimmune Biology, Volume 7. Berczi I, Szentivanyi A. Series editors. Elsevier, Amsterdam, 2006. (submitted).
65. Berczi I. Szentivanyi A. Preface. In The Hypothalamus-Pituitary-Adrenal Axis. DelRey A, Chrousos G, Besedovsky H. Editors, Neuroimmune Biology, Volume 7. Berczi I, Szentivanyi A. Series editors. Elsevier, Amsterdam, 2006. (submitted).
66. Jancso G. Neurogenic inflammation in health and disease. Neuroimmune Biology, Volume 8. Berczi I, Szentivanyi A. Series editors. Elsevier, Amsterdam, 2006. (submitted).
67. Berczi I. Szentivanyi A. Foreword: Neurogenic Inflammation Coming of Age. In Neuroimmune Biology, Volume 8. Berczi I, Szentivanyi A. Series editors. Elsevier, Amsterdam, 2006. (submitted).
68. Berczi I, Arnason B, Buckingham J. Editors, The brain and host defense. Neuroimmune Biolody, Volume 9, Berczi I, Szentivanyi A. Series editors, Elsevier, Amsterdam, (in preparation).

 

 

Medical School of Debrecen, Hungary
Medical School of Debrecen
Debrecen , Hungary

        CURRICULUM VITAE

Andor Szentivanyi, M.D., D.Sc.  

Date and Place of Birth:  May 4, 1925; Miskolc, Hungary

Citizenship:  United States of America

 Education and Training 

University:  University Medical School of Debrecen, Hungary 1944-1950

Degree of Doctor of Medicine: University Medical School of Debrecen  Debrecen, Hungary   1950

Rotating Internship:  Hospitals of the University Medical School of  Debrecen, Hungary  1950

Residency:                    Internal Medicine

                                    Department of Internal Medicine of the University

                                    Medical School of Debrecen, Debrecen, Hungary  1950-1952

                                    Department of Internal Medicine of the University

                                    Medical School of Budapest, Budapest, Hungary 1953

Specialty Board:  Specialty Board in Internal Medicine,  Budapest, Hungary  1954

 Academic Appointments

 University Distinguished Professor of Internal Medicine and Pharmacology and Professor of Neurology, University of South Florida College of Medicine, Professor of Environmental and Occupational Health, University of South Florida College of Public Health, Tampa, Florida 1987-present

 Dean of the College of Medicine, Deputy Vice President for Medical, Affairs, Chairman of the Department of Pharmacology and Therapeutics, Professor of Pharmacology and Internal Medicine, Affiliate Professor of Human Values, Univerity of South Florida College of Medicine, Tampa, Florida  1985-1986

Vice President for Medical Affairs, Dean of the College of Medicine, Chairman of the Department of Pharmacology and Therapeutics, Professor of Pharmacology and Internal Medicine, Affiliate Professor of Human Values, University of South Florida College of Medicine, Tampa, Florida  1983-1985

 Director of the Medical Center, Dean of the College of Medicine, Chairman of the Department of Pharmacology and Therapeutics, Professor of Pharmacology and Internal Medicine, University of  South Florida College of Medicine, Tampa, Florida  1980-1983

 Interim Director of the Medical Center, Interim Dean of the College of Medicine, Chairman of the Department of Pharmacology and Therapeutics, Professor of Pharmacology and Internal Medicine,University of South Florida College of Medicine, Tampa, Florida 1980

 Chairman and Professor, Department of Pharmacology and Therapeutics, Professor of Internal Medicine, Associate Dean for Research and Graduate Studies, University of South Florida, College of Medicine,Tampa, Florida 1978-1980

 Chairman and Professor, Department of Pharmacology and Therapeutics, University of South Florida College of Medicine, Tampa, Florida  1970-1986

 Chairman and Professor, Department of Medical Microbiology and Immunology, Professor of Internal Medicine, Creighton University School of Medicine, Omaha, Nebraska 1967-1970

 Associate Professor of Pharmacology, Internal Medicine and Microbiology, University of Colorado School of Medicine, Denver, Colorado  1965-1967

 Assistant Professor of Pharmacology and Microbiology, University of Colorado School of Medicine, Denver, Colorado 1963-1965

 Assistant Professor of Internal Medicine, Department of Internal Medicine, University of Colorado School of Medicine, Denver, Colorado  1962-1965

Instructor in Internal Medicine Department of Internal Medicine, University of Colorado School of Medicine, Denver, Colorado 1961-1962

United States Public Health Service Special Fellow in Internal Medicine, Department of Internal Medicine,

University of Colorado School of Medicine, Denver, Colorado 1959-1960

 Rockefeller Fellow in Internal Medicine Department of Internal Medicine, The University of Chicago, Chicago, Illinois 1957-1959

 Assistant Professor of Internal Medicine, Department of Internal Medicine of the University

Medical School of Budapest, Budapest, Hungary 1953-1956

 Honors and Awards

Member, Drug Committee, American Academy of Allergy 1968-present

Member, Editorial Board, Annals of Allergy 1968-1982

The Heinrich Klüver Award 1969

Member, Allergy Testing Program Committee (for Pharmacology, National Board of Medical Examiners,     1972) 1971-present

Florida Coordinator for National Correspondents, FASEB 1971-present

Outstanding Professor Award, University of South Florida College of Medicine 1972

Member, Southern Region Research Review and Certification Subcommittee of the American Heart             Association 1972-1978

Member, Research Committee, Florida Heart Association 1972-1978

Member, Editorial Board, International Archives of Allergy and Applied Immunology 1973-1985

Member, Council of Section on Allergy of Pan American Medical Assn. 1973-present

Member, Editorial Board, Allergologia et Immunopathologia 1977-1991

Prix Pasteur 1977

Doctor of Medicine, (D.M.; honoris causa), University of Saarland Homburg, Federal Republic of Germany   1977                                                           

 The Luis F. Leloir Award 1978

Honorary Fellow, Asociación de Alergia e Inmunopathología del Litoral 1978-present

Honorary Fellow, Asociación Argentina de Alergia e Inmunología 1978-present

Member, Editorial Board, Clinical Immunology Newsletter 1978-1988

Commendation Medal, Florida Heart Association 1978

Honorary Member, Asociación Argentina de Alergia e Inmunología, Buenos Aires, Argentina 1978

Honorary Fellow, Chilean Society for Allergy and Immunology (Sociedad Chilena de Alergia e             Inmunología) 1979-present

Honorary Fellow, Chilean Foundation for Bronchial Asthma (Fundación Para el Asma Bronquial) 1979-present

The Walter R. Hess Award 1979

The Clemens Freiherr von Pirquet Prize 1980

Member, Editorial Board, The Reticuloendothelial System 1980-1988

Member, Editorial Board, EOS-Journal of Immunology and Immunopharmacology 1981-present

Theodore and Venette Askounes-Ashford Distinguished Scholar Award 1981

Doctor of Philosophy (D.Phil; honoris causa), Université de Clermont-Ferrand, Clermond-Ferrand, France   1981

Honorary Member, The Royal Spanish Academy of Medicine 1981

The Distinguished Service Award of the American-Hungarian Foundation 1983

The Abraham Lincoln Award of the American-Hungarian Foundation 1984

Honorary Member, German Society for Allergy and Immunology (Deutsche Gesellschaft für Allergie und      Immunitatsforschung) 1984

Honorary Fellow, Collegium Hungaricum Louvain, Louvain, Belgium 1984

The Stephen W. Ranson Award 1984

Member, Editorial Board, Revista Argentina de Asma, Alergia e Inmunología 1984-present

National Vice Chairman, Honor Committee for Presentation of The George Washington Award to United States Ambassador to Hungary, Mr. S. Salgo, 1985

Paper in Journal of Allergy 42:203, 1968, named "Citation Classic" by Current Contents 1985

National Chairman, Honor Committee for the Posthumous Presentation of The George Washington Award    to the late Ambassador of Sweden to Hungary, Mr. Raoul Wallenberg, New York, New York  1986

Co-Editor, Immunopharmacology Reviews 1987-present

University Distinguished Professorship of Internal Medicine and Pharmacology of the University of South Florida College of Medicine 1987-present

Doctor of Science, University of Malaga, Malaga, Spain 1988

Member, Editorial Board, Laboratory Immunology 1988-present

The Dag Hammarskjöld International Award for Medicine 1988

Member, Editorial Board, Journal of Investigative Allergology and Clinical Immunology 1991-present

Honorary Member, Florida Allergy and Immunology Society 1991-present

National Chairman, Task Force on Higher Education and Institutional Research, Republican Senatorial Committee and Republican Senatorial Inner Circle, The Ronald Reagan Republican Center, Washington,      D.C. 1991-1994

The Senatorial Commission Award, the Republican Senatorial Committee, the Ronald Reagan Republican    Center, Washington, D.C. 1991

The Abraham Lincoln Award, the Republican Senatorial Committee, the Ronald Reagan Republican Center, Washington, D.C. 1991

Honorary Member, Committee on Immunopharmacology, American Society for Pharmacology and Experimental Therapeutics 1992-1996

Distinguished Research Professor, University of South Florida 1993-present

 University Research Medallion Award, University of South Florida 1993

Medal of Freedom Award, the Republican Senatorial Committee Washington, D.C. 1994

The Donn L. and Ruth E. Smith Founder Award, University of South, Florida College of Medicine 1994

 Memberships 

Memberships on numerous NIH and HEW site visits, regular and ad hoc Study Sections of the National       Heart and Lung Institute, and the National Institute of Allergy and Infectious Diseases (1965-1987)

Member, Federation of American Societies for Experimental Biology 1963-present

Member, American Society for Pharmacology and Experimental Therapeutics 1974-present

Fellow, American College of Clinical Pharmacology 1974-present

Member, American Society for Clinical Pharmacology and Therapeutics 1974-present

Member, Association of Medical School Pharmacology Chairmen 1970-1987

Member, American Association of Immunologists 1963-1987

Fellow, American Academy of Allergy 1966-present

Fellow, American College of Allergists 1966-present

Fellow, Royal Society for Health (England) 1971-present

Member, International Association of Asthmology (INTERASMA) 1976-present

Fellow, the American Association for Clinical Immunology and Allergy 1978-present

Member, Society of Leukocyte Biology 1989

Member, the Naples Institute for Advanced Studies in Medicine and the Humanities 1980-present

 Invited Lectureships and/or Visiting Professorships 

University of Pennsylvania School of Medicine (Department of Psychiatry) 1961

Fourth Aspen International Conference on Research in Emphysema andAsthma, Aspen, Colorado 1961

University of Wisconsin Medical School (Department of Pharmacology) 1965

The Oscar Menderson Schloss Memorial Lecture, Cornell University College of Medicine (Department of    Pharmacology) 1965

The Leonard Noon Lecture, Wright-Fleming Institute, St. Mary's Hospital Medical School, London,             England 1965

Symposium on New Approaches to Study of Clinical Manifestations of Human Infection and Allergy,            National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda,             Maryland 1966

New York Medical College (Department of Medicine) 1966

Symposium on Animal Models of Respiratory Disease, National Heart and

Lung Institute, Scripps Clinic and Research Foundation, LaJolla, California 1967

Symposium on Research in Asthma and Other Allergic Disorders, National Institute of Allergy and Infectious Diseases, National Jewish Hospital and Research Center, Denver, Colorado 1967

Mayo Post-Graduate School of Medicine of the University of Minnesota (Department of Medicine) 1968

University of California, San Francisco, School of Medicine (Department of Pediatrics) 1968

New York University School of Medicine (Department of Pathology) 1969

The Steven Rothmann Memorial Lecture, the University of Chicago (Department of Medicine) 1969

Boston University School of Medicine (Department of Psychiatry) 1969

Harvard Medical School, Department of Medicine (Robert B. Brigham Hospital) 1969

University of Iowa School of Medicine (Department of Medicine) 1969

University of Colorado School of Medicine (Department of Pediatrics) 1969

The Robert A. Cooke Lecture, Robert A. Cooke Institute of Allergy, Columbia University College of            Physicians and Surgeons, New York 1970

Jefferson Medical College, Department of Medicine, Philadelphia, PA 1970

Gordon Conference on Cyclic AMP, Plymouth, New Hampshire 1970

Medical College of Georgia (Department of Pharmacology) 1971

Biology Education Lecture Series:  Pulmonary Pharmacology Upjohn Company, Kalamazoo, Michigan   1972                                                           

American Medical Association Convention, San Francisco, California  1972

The Ignacz Semmelweis Memorial Lecture, Department of Obstetrics and Gynecology, Temple University    School of Medicine 1973

Midwest Clinical Conference, Chicago Dermatological Society, Chicago 1973

"The Search for Mental Health," Forest Hospital, Des Plaines, Illinois 1973

Progress in Asthma Control Symposium, World Health Information Services, Washington, D.C 1973

Schering Corporation, Educational film on Allergy 1973

VII International Congress of Allergology, Tokyo, Japan 1974

Schering International Symposium on Asthma, National Jewish Hospital and Research Center, Denver,         Colorado 1975

Jimenez Diaz Lecture, Instituto de Investigaciones Clínicas y Médicas de la Universidad de la Immaculada    Concepción, Madrid, Spain 1977

VI Latin American Congress of Allergy and Immunology, Guaruja, Brazil 1977

The Butantan Institute (Department of Immunology), Sao Paulo, Brazil 1977

Second International Meeting of Asmology, Torremolinos, Spain 1977

Deutsche Klinik fur Diagnostik (German Mayo Clinic), Wiesbaden, Federal Republic of Germany 1977

The Rudolf Magnus Lecture, Institute of Pharmacology, Utrecht University, The Netherlands; The Rudolf     Magnus Professor of Pharmacology of 1977

Ciba-Geigy Asthma Symposium, St. Petersburg, Florida 1978

Ninth Congress of the International Association of Asthmology, New Orleans, Louisiana 1978

The Television Network for Continuing Medical Education, film on the Beta Adrenergic Theory of Atopic     Disorders, New York City 1978

The Arao J. Mendes Lecture, the Medical Institute of the Pontifical Catholic University of Rio de Janeiro,     Brazil 1978

The Eric Leicles Lecture, University of Nottingham, England 1978

Conference on the Physiopathology of the Atopic State, Rosario, Argentina 1978

The Luis F. Leloir Lecture, Institute for Biochemical Investigations, Buenos Aires, Argentina 1978

University of Oxford, Sir William Dunn School of Pathology, Oxford, England 1978

The M. Pasteur Valery-Radot Memorial Lecture, College de France, Universite de Paris (Sorbonne), France 1979

International Symposium on Atopic Dermatitis, Oslo, Norway 1979

The J. Jadassohn Lecture, the Dermatological Institute, University of London, England 1979

The Journees d'Enseignement Post-Universitaires d'Alergo-Immunologie, Universite Aix-Marseille,             Marseille, France 1979

International Symposium on Childhood Asthma in the International Year of the Child, Santiago, Chile 1979

Annual Congress of the Sociedad Chilena de Dermatología y Venereología, Santiago, Chile 1979

Basel University, Department of Pharmacology, Basel, Switzerland 1979

IX International Congress of Allergology, Jerusalem, Israel 1979

The Academic Inauguration Lecture, The Royal Academy of Medicine (Real Academia de Medicina),          Barcelona, Spain 1980

Free University of Berlin (Department of Internal Medicine), Berlin Federal Republic of Germany 1980

The Sandoz International Symposium on Ketotifen, Paris, France 1980

The Clemens Freiherr von Pirquet Memorial Lecture, University of Vienna, Department of Pediatrics,           Vienna, Austria 1980

The VII Latin American Congress of Allergy and Immunology, Caracas, Venezuela 1980

XVII National Reticuloendothelial Society Meeting, Tampa, Florida 1980

International Symposium on Adrenergic Receptor Pharmacology, Augusta, GA 1980

XXXVII Congress of the American Academy of Allergy, San Francisco, CA 1981

Fison's International Symposium on "Update on Bronchial Hypersensitivity," Washington, D.C. 1981

International Symposium on "Cellular and Humoral Responses in Allergic Disease," Montreal, Canada 1981

Annual Congress of the European Academy of Allergology and Clinical Immunology, Faculty of Medicine,   Clermont-Ferrand, France 1981

Xth Interasma Congress, Hospital des Enfants Malades, Paris, France 1981

International Symposium on Drug Hypersensitivity, Rosario, Argentina 1981

XXXVIIth Annual Congress of the American College of Allergists, Washington, D.C. 1981

International Symposium on Medicine and Health Care Delivery Systems in Various Countries, the Naples   Institute for Advanced Studies in Medicine and the Humanities, Naples, Florida 1981

VII Colloquy on Immunology and Allergology, Pamplona, Spain 1981

International Symposium on Recent Aspects of the Role of Histamine in Immunologic Inflammation,             Collège de France, Paris, France 1981

The New York Academy of Sciences Symposium on Cell Surface Receptors, New York, New York 1982

Kongress der ärztlichen Arbeitsgemeinschaft für angewandte Allergologie Acron Verlag Manfred             Bolschakoff, West Berlin, Federal Republic of Germany 1982

Institute of Medical Microbiology and Hygiene, The Free University of  Berlin, West Berlin, Federal             Republic of Germany 1982

The Robert Koch Institute, West Berlin, Federal Republic of Germany 1982

International Symposium on Biological Response Modifiers in Clinical Oncology and Immunology, Tampa,  Florida 1982

Plenary Symposium on Asthma and Research, XI International Congress of  Allergology and Clinical             Immunology, London, England 1982

First International Meeting on Bronchial Asthma sponsored by the Instituto Argentino de Alergia e             Inmunología, Mar del Plata, Argentina 1982

Schering Lecture, West Berlin, Federal Republic of Germany 1982

First Interamerican Congress of Clinical Pharmacology and Therapeutics, Caracas, Venezuela 1982

Symposium on Medical Applications of Microcomputers, Tampa, Florida 1982

Symposium on Clinical Laboratory Immunology, Clearwater, Florida 1982

International Conference of the Nederlands Astma Fonds, Utrecht, The Netherlands 1982

Second International Congress for Interferon Research, Miami, Florida 1982

The Lorenzini Foundation Symposium on Cyclic Nucleotides and Protein Phosphorylation, Universita Degli   Studi di Milano, Italy 1983

XVI International Congress of Dermatology, Tokyo, Japan 1983

International Conference on Opportunities in Medicine, San Juan, P.R. 1983

Annual Meeting of the Hungarian Society for Allergy and Clinical Immunology, Szeged, Hungary 1983

International Symposium on Signal and Signal Processing in the Immune System:  Non-antigen Receptors,    Balatonfured, Hungary 1983

Third International Sanrocco Symposium, Menaggio, Italy 1983

Second International Symposium on Atopic Dermatitis, Trondheim, Norway 1983

International Symposium on Receptor Biology, National Institutes of Health, Bethesda, Maryland 1983

The Twenty-Third Gaddum Memorial Lecture, School of Pharmacy, University of London, London 1983

First World Conference on Inflammation, Antirheumatics, Analgesics, and Immunomodulators, Venice,         Italy 1984

International Symposium on Immunomodulation, Stichting Studiencentrum voor Allergie-Projecten,             Haarlem, The Netherlands 1984

Asthma and Bronchial Hyperreactivity, European Society of Pneumology, Basel, Switzerland 1984

 International Symposium on the Immunobiology and Immunopharmacology of Bacterial Endotoxins - Basic and Clinical Aspects, Tampa, Florida 1984

The Lenhossek Lecture, Rega Institute, Katholieke Universiteit Leuven, Leuven, Belgium 1984

International Symposium on Viruses, Immunity and Immunodeficiency, Clearwater, Florida 1984

Smith, Kline and French International Symposium on the Biochemical Pharmacology of Inflammation,           Lima, Peru 1984

Southeastern Branch of the American Society of Microbiology Symposium on Modulation of Immune          Responses by Bacterial Products, Clearwater, Florida 1984

Symposium on Antibiotics and Host Immunity, Siena, Italy 1984

Third International Conference on Immunopharmacology, Florence, Italy 1984

The Ninth Ernest Witebsky International Convocation on Immunology on "Antibodies:  Protective,             Destructive, and Regulatory Role," Buffalo, New York 1984

International Symposium on Allergy and Immunology, Lima, Peru 1984

XI World Congress of Asthmology, International Association of Asthmology, Mexico City, Mexico 1984

International Symposium on Clinical Virology, Tampa, Florida 1985

Alfred Benzon Symposium on Dynamic Processes in Membranes and Cells Versus the Drug Receptor         Concept, Copenhagen, Denmark 1985

First Purdue Frederick Symposium on Methylxanthine Therapy, Boca Raton, Florida 1985

International Symposium on Immumomodulation by Endotoxin and its Fragments, Jerusalem, Israel 1985

Instituto di Microbiologia, Bari, Italy 1986

XIV International Cancer Congress, Budapest, Hungary 1986

International Symposium on Immumomodulation, Copanello, Italy 1986

XI International Congress of Transplant Society, Helsinki, Finland 1986

International Symposium on Immunological Adjuvants and Modulators of Nonspecific Resistance to             Microbial Infections, Columbia, Maryland 1986

II International Congress on Inflammation, Monte Carlo, Monaco 1986

International Symposium on the Nature, Cellular, and Biochemical Basis and Management of             Immunodeficiencies, Hoechst Pharmaceuticals, Munich, Federal Republic of Germany 1986

 Fifth International Lymphokine Workshop on the Molecular Basis ofLymphokine Action,             Clearwater Beach, Florida 1987

The Second Sandoz International Symposium on the Recognition and Management of Immunodeficient         Disorders, St. Petersburg, Florida 1987

The Third International Symposium on the Influence of Antibiotics on the Host-Parasite Relationship,             Cologne, Federal Republic of Germany 1987

The Günther Gillissen Oration, University of Aachen Medical School, Aachen, Federal Republic of             Germany 1987

XII World Congress of Asthmology, International Association of Asthmology, Barcelona, Spain 1987

Second Annual H. Lee Moffitt International Symposium on Cancer Biology and Therapeutics, Tampa,         Florida 1987

Second International Meeting on Respiratory Allergy, Sorrento, Italy 1988

International Symposium on Endotoxin, Jichi Medical School, Tochigi-Ken, Japan 1988

Fourth International Conference on Immunopharmacology, International Society of Immunopharmacology,   Osaka, Japan 1988

Honarary President, Symposium on Interactions between the Neuroendocrine and Immune Systems,             International Society of Immunopharmacology, Copanello, Italy 1988

The Dag Hammarskjöld Lecture, Trinity College, Dublin, Ireland 1988

International Conference of Pharmacologists from Universities and Industry, Institute of Clinical             Pharmacology, Sir Patrick Dun's Hospital, Dublin, Ireland 1988

XVI World Congress of Asthmology, International Association of Asthmology, Havana, Cuba 1988

Seventh Congress of the European Society of Pneumology, Budapest, Hungary 1988

XIII International Congress of Allergology and Clinical Immunology, International Association of             Allergology and Clinical Immunology, Montreux, Switzerland 1988

XXI Brazilian Congress of Allergy and Immunology, Florianopolis, Brazil 1988

Cambridge Symposium on Myalgic Encephalomyelitis, Cambridge University, England 1990

Department of Psychiatry, Boston University, Boston, Massachusetts 1990

International Conference on the RES and Leukocyte Biology, Heraklion, Crete, Greece 1990

Presiding chairman and/or moderator of numerous scientific sessions, postgraduate panels, and other forums at Congresses of the American Academy of Allergy, American College of Allergists, The Federation  Societies for Experimental Biology (The American Association of Immunologists, the  American Society of Pharmacology and Experimental Therapeutics), Gordon Conferences, International Association of Asthmology, Cold Spring Harbor Symposia on Quantitative Biology, Aspen International Conferences on Research in Emphysema and Asthma and various international symposia and conventions 1965-present

 University/College Committees 

Univeristy of Colorado: Committees on Internal Research Grants, Human Experimentation,             Interdepartmental Seminars on Perspectives in Biology, Library, Clinical Pharmacology and ad hoc

Committees on Promotion and Tenure

Creighton University:     Committee on Curriculum Reforn, Executive Committee of the School of             Medicine, Task Force on University

Mission, Council for Institutional Development, Committee on Human Experimentation, Committee on          Hospital Planning, Committee on Rank and Tenure, various ad hoc

Search Committee for Chairmen and Deans

University of Committee on By-Laws, Committee on Admissions, Committee South Florida:  on Research,   Executive Council of the College of Medicine Committee on Curriculum, Committee on Promotion  and Tenure

Committee on Graduate Studies, Task Force for Institutional

Self-Study, USF Faculty Senate, USF Graduate Council, USF

Committee on Role and Scope, USF Dean's Council, President's

Staff, Dean's VA Council, Tampa General Hospital Joint

Affiliation Committee, Medical Advisory Committee, USF

Foundation Board of Directors, Insurance Trust Fund

Council, Claims Committee, Board of Directors of the

University Medical Services Association, Inc., Board of Regents Study Committee on Health Planning and  Teaching

Hospitals, Committee on Medical Clinics, Board of Directors of the H. Lee Moffitt Hospital and Cancer      Research Institute at the University of South Florida, and a number of ad hoc

Search Committees for Chairmen and Deans as well as various subcommittees of existing standing             committees

 

Community Service 

Internal Actions Task Force for Committee of 100 of The Greater Tampa Chamber of Commerce 1980-1986

Community Health Care Council of Greater Tampa Chamber of Commerce 1980-1986

USF Medical Liaison Committee of the Hillsborough County Medical Association 1980-1986

Tampa Bay Area Council on Foreign Relations 1980-present

Board of Trustees for the Foundation for Eye Research, Inc. 1980-1986

Community Hospitals Education Council of Florida 1980-1986

Council on Scientific Activities, Florida Medical Association 1980-1984

Committee on Medical Education, Florida Medical Association 1980-1984

Board of Directors of the H. Lee Moffitt Cancer Center and Research Institute at the University of South   Florida 1980-1986

Board of Directors of the Heineman Medical Research Center, Charlotte, North Carolina 1982-1987

  

List of Publications 

Twenty-six papers have been published in the Hungarian language.  Here are listed only those publications which have appeared either in English, German, French or Spanish. 

27.            Filipp, G, Szentivanyi, A, and Mess, B:  Anaphylaxis and nervous system.  Acta. med. hung., Tomus III, Fasciculus 2:163, 1952.

28.            Szentivanyi, A, Filipp, G, and Legeza, I:  Investigations on tobacco sensitivity.  Acta. med. hung., Tomus III, Fasciculus 2:175, 1952.

29.            Filipp, G, Szentivanyi, A, and Mess, B:  Anaphylaxie und Nerven system I. Orv Hetil (Budapest) 16:465-72, 1952.

30.            Szentivanyi, A, Filipp, G, and Mess, B:  Anaphylaxie und Nerven system II. Orv Hetil (Budapest) 19:1193-8, 1952.

31.            Filipp, G, and Szentivanyi, A:  Zur Frage der Organlokalisation der allergischen Reaktion, Wiernerklin. Wschr. 65:620, 1953.

32.            Szentivanyi, A:  Allergie und Zentralnervensystem. Proceedings of Second European Congress Allergology, Copenhagen, Denmark, May 20-23, 1953.  Acta. Allergologica 6:27, 1953.

33.            Fornet, B, Filipp, G, Vegh, L, and Szentivanyi, A:  Beeinflussung der experimentellen Anaphylaxie durch zisternal verabreichten Farbstoff.  Acta. med. hung., Suppl., Tomus VI, 115, 1954.

34.            Filipp, G, and Szentivanyi, A:  Experimentelle Data zur regulativen Rolle des Neuroendokriniums in experimenteller Anaphylaxie I. Relazioni e Communicazioni, 229, Rome I1 Pansiero Scientifico, 1956.

35.            Szentivanyi, A, and Filipp, G:  Experimentelle Data zur regulativen Rolle des Neuroendokirniums in experimenteller Anaphylaxie II. Relazioni e Communicazioni, 237, Rome I1 Pansiero Scientifico, 1956.

36.            Szentivanyi, A, and Szekely, J:  Effect of injury to, and electrical stimulation of hypothalamic areas on the anaphylactic and histamine shock of the guinea pig.  Ann. Allergy 14:259, 1956.

37.            Filipp, G, and Szentivanyi, A:  Die Wirkung von Hypothalamuslasionen auf den anaphylaktischen Schock des Meerschweinchens.  Allergie und Asthmaforschung, Bd. 1:12, 1957.

38.            Szentivanyi, A, and Szekely, J:  Uber den Effekt der Schadigung und der elektrischen Reizung der hypothalamischen Gegenden auf den anaphylaktischen und Histamin-Schock des Meerschweinchens Allergie und Asthmaforschung, Bd. 1:28, 1957.

39.            Szentivanyi, A, and Szekely, J:  Wirkung der konstanten Reizung hypothalamischer Strukturen durch Tiefenelektroden auf den histaminbedingten und anaphylaktischen Schock des Meerschweinchens.  Acta. Physiol. Hung. Suppl. V. 11, Tomus XI, 41-42, 1957.

40.            Szentivanyi, A, and Talmage, DW:  Glucocorticoid-induced selective changes in the incorporation pattern of S35-labeled amino acids into proteins of various tissues. Relationships to mechanism of anti-inflammatory activity.  In:  "Proceedings of the Third International Congress of Allergology," Paris, France, 1958, p. 131.

41.            Filipp, G, Szentivanyi, A, Keszthelyi, M, Demeny, P, and Haraszthy, A:  Histaminazoprotein im Tierversuch und in der Therapie allergischer Krankheiten.  Allergie und Asthma, Bd. 4:151, 1958.

42.            Szentivanyi, A, and Filipp, G:  Anaphylaxis and the nervous system. Part II.  Ann. Allergy 16:143, 1958.

43.            Filipp, G, and Szentivanyi, A:  Anaphylaxis and the nervous system. Part III.  Ann. Allergy 16:306, 1958.

44.            Szentivanyi, A, and Szekely, J:  Anaphylaxis and the nervous system. Part IV.  Ann. Allergy 16:389, 1958.

45.            Weiler, RJ, Hofstra, D, Szentivanyi, A, Blaisdell, R, and Talmage, DW:  The inhibition of labeled antigen precipitation as a measure of serum gamma globulin.  J. Immunol. 85:130, 1960.

46.            Szentivanyi, A, Hruban, Z, Radovich, J, and Talmage, DW:  Inhibition of incorporation of S35-labeled amino acids into tissue and serum proteins by beta-3-thienyl-DL-alanine.  J. Infect. Dis 109:223, 1960.

47.            Szentivanyi, A, Radovich, J, and Talmage, DW:  The separation of free, disulfide-bound and peptide-bound S35 radioactivity in serum and tissues.  J. Infect. Dis. 109:231, 1961.

48.            Szentivanyi, A, Radovich, J, and Talmage, DW:  Effect of cortisone on the incorporation of S35-labeled amino acids into serum and tissue proteins.  Federation Proc. 20:379, 1961.

49.            Talmage, DW, Szentivanyi, A, and Radovich, J:  A lag in the maximum incorporation of S35-labeled amino acids in circulating gamma globulin.  Federation Proc. 20:24, 1961.

50.            Szentivanyi, A:  Hypothalamic influences on antibody formation and on bronchial responses to histamine.  In:  "Proceedings of the Fourth Aspen Conference on Research in Emphysema and Asthma," Aspen, Colorado, 1961, p. 78.

51.            Linaweaver, WE, Hurst, D, and Szentivanyi, A:  Equilibrium dialysis studies on the in vitro binding of histamine-2-(ring)-C14 by RNA, DNA, heparin, and chondroitin sulfate.  In:  "Proceedings of the Fourth Congress of the International Association of Allergology," New York, New York, 1961, p. 81.

52.            Szentivanyi, A, Linaweaver, WE, and Hurst, D:  Equilibrium dialysis studies on the in vitro binding of histamine-2-(ring)-C14 and 5-hydroxytryptamine-1-C14 by plasma proteins of various mammalian species.  In:  "Proceedings of the Fourth Congress of the International Association of Allergology," New York, New York, 1961, p. 82.

53.            Fishel, CW, Szentivanyi, A, and Talmage, DW:  Sensitization and desensitization of mice to histamine and serotonin by neurohumors.  J. Immunol. 89:8, 1962.

54.            Fishel, CW, and Szentivanyi, A:  The absence of epinephrine-induced hyperglycemia in pertussis-sensitized mice.  Federation Proc. 21:271, 1962.

55.            Szentivanyi, A:  The reciprocal histamine-adrenaline "counterregulation" - a physiological interplay.  In:  "Proceedings of the Annual Meeting of the Rocky Mountain Allergy Society," Denver, Colorado, 1962.

56.            Fishel, CW, and Szentivanyi, A:  The absence of adrenaline-induced hyperglycemia in pertussis-sensitized mice and its relation to histamine and serotonin hypersensitivity.  J. Allergy 34:439, 1963.

57.            Szentivanyi, A, Fishel, CW, and Talmage, DW:  Adrenaline mediation of histamine and serotonin hyperglycemia in normal mice and the absence of adrenaline-induced hyperglycemia in pertussis-sensitized mice.  J. Infect. Dis. 113:86, 1963.

58.            Radovich, J, Szentivanyi, A, and Talmage, DW:  The lack of selective reincorporation into tissue protein of amino acids derived from catabolism of serum protein.  J. Gen. Physiol. 47:297, 1963.

59.            Fishel, CW, Szentivanyi, A, and Talmage, DW:  Adrenergic Factors in Bordetella pertussis-induced Histamine and Serotonin Hypersensitivity of Mice.  In:  "Bacterial Endotoxins," M. Landy and W. Braun, eds., Rutgers University Press, New Brunswick, NJ, 1964, pp. 474-481.

60.            Cohen, EP, Petty, TL, Szentivanyi, A, and Priest, RE:  Clinical and pathological observations in fatal bronchial asthma:  Report of a case treated with the immunosuppressive drug, azathioprine.  Ann. Int. Med. 62:103, 1965.

61.            Szentivanyi, A, and Fishel, CW:  Effect of Bacterial Products on Responses to the Allergic Mediators.  In:  "Immunological Diseases," M. Samter, ed., Little, Brown and Company, Boston, MA, 1965, pp. 226-241.

62.            Townley, RG, Trapani, IL, and Szentivanyi, A:  Comparison of beta-adrenergic blockade with pertussis-induced hypersensitivity.  Federation Proc. 25:692, 1966.

63.            Townley, RG, Trapani, IL, and Szentivanyi, A:  Species and strain differences in hypersensitivity to pharmacological mediators produced by beta-adrenergic blocking agents.  J. Allergy 37:101, 1966.

64.            Szentivanyi, A, and Fishel, CW:  Die Amin-Mediatorstoffe der allergischen Reaktion und di e Reaktionsfahiegheit ihrer Erfolgszellen.  In:  "Pathogenese und Therapie allergischer Reaktionen.  Grundlagenforschung und Klinik," G. Filipp, and A. Szentivanyi, eds., Ferdinand Enke Verlag, Stuttgart, Germany, 1966, pp. 588-683.

65.            Szentivanyi, A:  The biochemical pharmacology of adrenergic action as related to the pathogenesis of bronchial asthma.  Ann. Allergy 24:253, 1966.

66.            Szentivanyi, A:  Bacterial hypersensitivity in relation to bronchial obstruction.  In:  "Proceedings of the Symposium on New Approaches to Study of Clinical Manifestations of Human Infection and Allergy," USPHS National Institute of Allergy and Infectious Diseases, Bethesda, MD, 1966, p. 136.

67.            Szentivanyi, A:  Adrenergic pharmacology and the pathogenesis of bronchial asthma.  In:  "Proceedings of the Symposium on Research in Asthma and Other Allergic Diseases," USPHS National Institute of Allergy and Infectious Diseases, Denver, CO, 1967, p. 17.

68.            Townely, RG, Trapani, IL, and Szentivanyi, A:  Sensitization to anaphylaxis and to some of its pharmacological mediators by blockade of beta adrenergic receptors.  J. Allergy 39:177, 1967.

69.            Katsh, S, and Szentivanyi, A:  Dissociation of the histamine-sensitizing and histidine decarboxylase-enhancing activities of the Bordetella pertussis cell.  J. Allergy 41:106, 1968.

70.            Szentivanyi, A, Katsh, S, and Townley, RG:  Effect of pertussis sensitization and pharmacological beta-adrenergic blockade on the in vitro uptake of D-glucose-2-C14 into glycogen of diaphragm and upon the formation of C14O2 from glucose-1C14 by adipose tissue.  J. Allergy 41:107, 1968.

71.            Townley, RG, and Szentivanyi, A:  Secretion of immunoreactive insulin (IRI) by the isolated perfused pancreas of normal and pertussis-sensitized rats.  J. Allergy 41:122, 1968.

72.            Pearlman, DS, and Szentivanyi, A:  Excessive Reactivity of Defense Mechanisms--Allergy.  In:  "The Biologic Basis of Pediatric Practice," R.E. Cook, ed., McGraw-Hill Book Co., New York, NY, 1968, pp. 536-546.

73.            Szentivanyi, A, Katsh, S, and McGarry, B:  Lack of correlation between the histamine sensitizing and histidine decarboxylase activating effects of Bordetella pertussis.  Federation Proc. 27:268, 1968.

74.            Szentivanyi, A:  The beta adrenergic theory of bronchial asthma:  An alternative to the classical concept.  In:  "Proceedings of the 24th Annual Congress of the American College of Allergists,"  Denver, CO,  March 25-29, 1968, Abstract No. 9.

75.            Szentivanyi, A:  An adrenergic interpretation of the role of endotoxins in infection associated with bronchial asthma.  In:  "Proceedings of the 24th Annual Congress of the American College of Allergists," Denver, CO, March 25-29, 1968, Abstract No. 26.

76.            Szentivanyi, A:  The beta adrenergic theory of the atopic abnormality in bronchial asthma.  J. Allergy 42:203, 1968.

77.            Szentivanyi, A:  Discussion:  Immunologic Etiology, Animal Models of Respiratory Disease.In:  "Proceedings of the USPHS National Heart and Lung Institute Symposium," La Jolla, CA, Yale J. Biol. Med. 40:518, 1968.

78.            Katsh, S, Halkias, DG, and Szentivanyi, A:  Analysis of the structural requirements for the histamine-sensitizing activity of the beta adrenergic blocking agents.  J. Allergy 43:171, 1969.

79.            Halkias, DG, and Szentivanyi, A:  Reversal of the normal adrenergic suppression of peptide bond synthesis in protein of isolated rat diaphragm by pertussis sensitization in vitro.  Bacterial Proc., 1969, Abstract No. M22.

80.            Norwood, W, Szentivanyi, A, and Halkias, DG:  A method of monitoring airway resistance in dogs in the Honeywell Electronic System.  In:  "Proceedings of the 25th Annual Meeting of the American Academy of Allergy," Bal Harbor, FL, March 15-19, 1969, Abstract No. 74.

81.            Szentivanyi, A, Halkias, DG, and Katsh, S:  Effect of adrenergic blocking agents on the in vitro release and re-uptake of norepinephrine in isolated neuronal storage granules and its relation to histamine sensitization.  In:  "Proceedings of the 25th Annual Meeting of the American Academy of Allergy," Bal Harbor, FL, March 15-19, 1969, Abstract No. 65.

82.            Ortez, RA, Klein, TW, and Szentivanyi, A:  Impairment of the adenyl cyclase system in spleens of mice sensitized bacterially or by beta pharmacological blockade.  J. Allergy 45:111, 1970.

83.            Ortez, RA, Klein, TW, and Szentivanyi, A:  Cyclic AMP levels in spleens of pertussis-sensitized mice.  Federation Proc. 29:640, 1970.

84.            Szentivanyi, A:  Effect of Bacterial Products and Adrenergic Blocking Agents on Allergic Reactions.  In:  "Textbook of Immunological Diseases," M. Samter, D.W. Talmage, B. Rose, W.B. Sherman, and J.H. Vaughan, eds., Little, Brown and Co., Boston, MA, 1971, pp. 356-374.

85.            Ortez, RA, Fishel, CW, and Szentivanyi, A:  The reduced sensitivity of Bordetella pertussis vaccinated murine spleen and platelet adenyl cyclase to epinephrine.  Federation Proc. 31:748, 1972.

86.            Seshachalam, D, and Szentivanyi, A:  Glycogen metabolism of spleens in pertussis-sensitized mice.  In:  "Proceedings of the Fifth International Congress on Pharmacology," Bethesda, MD, 1972, p. 208.

87.            Szentivanyi, A, Fishel, CW, Krzanowski, JJ, and Polson, JB:  The clinical pharmacology of bronchial asthma in the conceptual frame of the beta adrenergic theory.  In:  "Proceedings of the AMA Convention," San Francisco, CA, June 18-22, 1972, p. 19.

88.            Fishel, CW, Szentivanyi, A, and Klein, TW:  Effect of epinephrine on plasma cyclic adenosine monophosphate levels of Bordetella pertussis-vaccinated and of adrenergically blocked mice.  Federation Proc. 32:1009, 1973.

89.            Polson, JB, Krzanowski, JJ, and Szentivanyi, A:  Effect of histamine on the pulmonary levels of cyclic nucleotides in normal mice and under conditions of pharmacologic or bacterial sensitization.  J. Allergy Clin. Immunol. 53:100, 1974.

90.            Krzanowski, JJ, Polson, JB, and Szentivanyi, A:  Energy metabolism and patterns of behavior of adenosine-3',5'-cyclic monophosphate in lung from control and bacterially sensitized mice under conditions of rest and adrenergic activation.  J. Allergy Clin. Immunol. 53:100, 1974.

91.            Fitzpatrick, DF, and Szentivanyi, A:  Histamine responses and beta-adrenergic blockade in guinea pig trachea in vitro - the role of calcium.  In:  "Proceedings of the Annual Meeting of the American Academy of Allergy," Miami Beach, FL, January 19-23, 1974.

92.            Krzanowski, JJ, Polson, JB, and Szentivanyi, A:  Histamine, isoproterenol, and epinephrine induced in vivo activation of adenyl cyclase in mouse lung following Bordetella pertussis.  The Pharmacologist 16:212, 1974.

93.            Polson, JB, Krzanowski, JJ, and Szentivanyi, A:  Effects of methacholine, histamine, and atropine on pulmonary guanosine-3',5'-cyclic monophosphate in hypersensitive mice.  The Pharmacologist 16:212, 1974.

94.            Polson, JB, Krzanowski, JJ, and Szentivanyi, A:  Histamine-induced changes in pulmonary guanosine-3',5'-cyclic monophosphate and adenosine-3',5'-cyclic monophosphate levels in mice following sensitization by Bordetella pertussis and/or propranolol.  Res. Commun. Chem. Pathol. Pharmacol. 9:243, 1974.

95.            Klein, TW, Szentivanyi, A, and Fishel, CW:  Effects of serotonin on platelets of normal and Bordetella pertussis-injected mice.  Proc. Soc. Exp. Biol. Med. 147:681, 1974.

96.            Szentivanyi, A, and Fishel, CW:  Neurohumoral concepts of bronchial asthma.  Act. Allergologica 29(Suppl. 11):26, 1974.

97.            Polson, JB, Krzanowski, JJ, and Szentivanyi, A:  Elevation of pulmonary cyclic GMP levels caused by histamine and methacholine in mice simulating atopic disease.  Adv. Cyclic Nucleotide Res. 5:815, 1974.

98.            Krzanowski, JJ, Polson, JB, and Szentivanyi, A:  In vivo alterations in adenosine-3',5'-cyclic monophosphate levels following adrenergic activation in animal models of atopic disease.  Adv. Cyclic Nucleotide Res. 5:819, 1975.

99.            Ortez, RA, Seshachalam, D, and Szentivanyi, A:  Alterations in adenyl cyclase activity and glucose utilization of Bordetella pertussis sensitized mouse spleen.  Biochem. Pharmacol. 24:1297, 1975.

100.        Fitzpatrick, DF, Krzanowski, JJ, and Szentivanyi, A:  Isolation of a Ca2+-binding system from respiratory smooth muscle.  J. Allergy Clin. Immunol. 55:134, 1975.

101.        Hackney, JF, and Szentivanyi, A:  The specificity of glucocorticoids in the relaxation of respiratory smooth muscle in vitro.  J. Allergy Clin. Immunol. 55:123, 1975.

102.        Krzanowski, JJ, Polson, JB, and Szentivanyi, A:  Theophylline attenuation of histamine-induced increases in pulmonary adenosine-3',5'-cyclic monophosphate.  J. Allergy Clin. Immunol. 55:133, 1975.

103.        Polson, JB, Krzanowski, JJ, and Szentivanyi, A:  Theophylline, theobromine and caffeine inhibition of cAMP and cGMP hydrolysis by respiratory smooth muscle phosphodiesterase.  J. Allergy Clin. Immunol. 55:133, 1975.

104.        Williams, JF, and Szentivanyi, A:  Implications of hepatic drug metabolizing activity in the therapy of bronchial asthma.  J. Allergy Clin. Immunol. 55:125, 1975.

105.        Polson, JB, and Szentivanyi, A:  Theophylline, theobromine, caffeine, and ICI 58,301 inhibition of adenosine-3',5'-cyclic phosphate and guanosine-3',5'-cyclic phosphate hydrolysis by canine tracheal smooth muscle phosphodiesterase.  Federation Proc. 34:261, 1975.

106.        Williams, JF, and Szentivanyi, A:  Effect of Bordetella pertussis vaccine on the drug-metabolizing enzyme system of mouse liver.  Federation Proc. 34:261, 1975.

107.        Krzanowski, JJ, Szentivanyi, A, and Tyler, DB:  Reduction of the histamine-induced increase in pulmonary adenosine-3',5'-cyclic monophosphate levels by theophylline.  Federation Proc. 34:332, 1975.

108.        Fitzpatrick, DF, Polson, JB, Krzanowski, JJ, and Szentivanyi, A:  Correlation of tracheal smooth muscle relaxation with phosphodiesterase inhibition.  The Pharmacologist 17:271, 1975.

109.        Hackney, JF, and Szentivanyi, A:  The unique action of glucocorticoid succinates on respiratory smooth muscle in vitro.  The Pharmacologist 17:271, 1975.

110.        Fishel, CW, Halkias, DG, Klein, TW, and Szentivanyi, A:  Characteristics of cells present in peritoneal fluids of mice injected intraperitoneally with Bordetella pertussis.  Infect. Immun. 13:263, 1976.

111.        Krzanowski, JJ, Polson, JB, and Szentivanyi, A:  Pulmonary patterns of adenosine-3',5'-cyclic monophosphate accumulations in response to adrenergic or histamine stimulation in Bordetella pertussis-sensitized mice.  Biochem. Pharmacol. 25:1631, 1976.

112.        Polson, JB, Krzanowski, JJ, and Szentivanyi, A:  Pulmonary guanosine-3',5'-cyclic monophosphate in sensitized mice:  Accumulations produced by H-1 receptor activation and evidence of altered phosphodiesterase activity.  J. Allergy Clin. Immunol. 57:265, 1976.

113.        Krzanowski, JJ, Polson, JB, and Szentivanyi, A:  Reduction in levels of pulmonary cyclic guanosine-3',5'-monophosphate induced by theophylline and isoproterenol.  J. Allergy Clin. Immunol. 57:265, 1976.

114.        Fitzpatrick, DF, and Szentivanyi, A:  The effects of protein kinase and cyclic nucleotides on calcium (Ca2+) uptake by rabbit aortic microsomes.  The Pharmacologist 18:182, 1976.

115.        Williams, JF, Polson, JB, and Szentivanyi, A:  Investigation of the pharmacological activity of the metabolites of the methylxanthines.  The Pharmacologist 18:181, 1976.

116.        Hackney, JF, and Szentivanyi, A:  The action of non-glucocorticoid steroid succinates on guinea pig trachealis muscle in vitro.  The Pharmacologist 18:182, 1976.

117.        Polson, JB, Krzanowski, JJ, and Szentivanyi, A:  Effects of methacholine, histamine and atropine on pulmonary guanosine-3',5'-monophosphate levels in hypersensitive mice.  Naunyn-Schmiedeberg's Arch. Pharmacol. 295:27, 1976.

118.        Szentivanyi, A, and Fishel, CW:  The Beta Adrenergic Theory and Cyclic AMP-Mediated Control Mechanisms in Human Asthma.  In:  "Bronchial Asthma:  Mechanisms and Therapeutics," E.B. Weiss and M.S. Segal, eds., Little, Brown and Co., Boston, MA, 1976, pp. 137-153.

119.        Krzanowski, JJ, Polson, JB, and Szentivanyi, A:  Evaluation of drug prototypes on pulmonary cyclic nucleotide levels.  In:  "Proceedings of the American Congress of Allergy and Immunology,"New York, Ann. Allergy 38:375, 1977, Abstract No. 68.

120.        Polson, JB, Krzanowski, JJ, Fitzpatrick, DF, and Szentivanyi, A:  Analysis of pharmacological phosphodiesterase inhibition and respiratory smooth muscle relaxation.  In:  "Proceedings of the American Congress of Allergy and Immunology," New York, Ann. Allergy 38:439, 1977.

121.        Williams, JF, Lowitt, S, and Szentivanyi, A:  Depression of hepatic drug metabolizing activity by Bordetella pertussis.  In:  "Proceedings of the American Congress of Allergy and Immunology," New York, Ann. Allergy 38:376, 1977, Abstract No. 70.

122.        Anderson, W, Krzanowski, JJ, Polson, JB, and Szentivanyi, A:  Murine cardiac and pulmonary cyclic nucleotide levels:  Fixation by freezing.  Federation Proc. 36:398, 1977.

123.        Brown, BS, Polson, JB, Krzanowski, JJ, and Szentivanyi, A:  Accentuated negative inotropic effects of methacholine in the presence of isoproterenol and decreased cyclic AMP levels in isolated rat atria.  Federation Proc. 36:283, 1977.

124.        Goldman, AL, Ebel, TA, Krzanowski, JJ, Polson, JB, and Szentivanyi, A:  Lung cyclic nucleotides in bronchospastic and nonreversible obstructive lung disease.  Amer. Rev. Resp. Dis. 115(Part 2):330, 1977.

125.        Williams, JF, and Szentivanyi, A:  Depression of hepatic drug-metabolizing enzyme activity by Bordetella pertussis vaccination.  Eur. J. Pharmacol. 43:281, 1977.

126.        Polson, JB, Krzanowski, JJ, Goldman, AL, Ebel, TA, and Szentivanyi, A:  Inhibition of human pulmonary phosphodiesterase by therapeutic levels of theophylline.  The Pharmacologist 19:203, 1977.

127.        Krzanowski, JJ, Polson, JB, and Szentivanyi, A:  Pulmonary cyclic nucleotide lowering after ganglionic blockade and prostaglandin synthetase inhibition.  The Pharmacologist 19:204, 1977.

128.        Fitzpatrick, DF, and Szentivanyi, A:  Stimulation of calcium uptake into aortic microsomes by cyclic AMP and cyclic AMP-dependent protein kinase.  Naunyn-Schmiedeberg's Arch. Pharmacol. 298:255, 1977.

129.        Szentivanyi, A, Williams, JF, Polson, JB, and Krzanowski, JJ:  Pathogenic mechanisms of asthma.  In:  "Proceedings of the VIth Latin American Congress of Allergy and Immunology," Guaruja, Sao Paulo, Brazil, 1977.

130.        Szentivanyi, A, Williams, JF, Szentivanyi, J, and Polson, JB:  Beta adrenergic dysfunction and atopic dermatitis.  In:  "Proceedings of the VIth Latin American Congress of Allergy and Immunology," Guaruja, Sao Paulo, Brazil, 1977.

131.        Szentivanyi, A, Fitzpatrick, DF, Williams, JF, Krzanowski, JJ, and Polson, JB:  A reinterpretation of the pharmacological basis of anti-asmatic drug therapy in the conceptual frame of the beta adrenergic theory and its relation to cyclic AMP-mediated cellular control mechanisms.  In:  "Proceedings of the Second International Meeting of Asthmology,"  Torremolinos, Spain, 1977.

132.        Krzanowski, JJ, Polson, JB, Goldman, AL, Ebel, TA, and Szentivanyi, A:  Cyclic nucleotide levels in human lung from patients with bronchospastic airway disease.  The Pharmacologist 19:203, 1977.

133.        Polson, JB, Krzanowski, JJ, Fitzpatrick, DF, and Szentivanyi, A:  Studies on the inhibition of phosphodiesterase-catalyzed cyclic AMP and cyclic GMP breakdown and relaxation of canine tracheal smooth muscle.  Biochem. Pharmacol. 27:254, 1978.

134.        Szentivanyi, A, Krzanowski, JJ, and Polson, JB:  The Autonomic Nervous System:  Structure, Function, and Altered Effector Responses.  In:  "Allergy:  Principles and Practice," E. Middleton, C.E. Reed, and E.F. Ellis, eds., The C.V. Mosby Company, St. Louis, MO, 1978, pp. 256-300.

135.        Krzanowski, JJ, Polson, JB, Anderson, WH, Lust, WD, and Szentivanyi, A:  A simple method for sampling murine pulmonary and cardiac tissues for analysis of cyclic nucleotide levels.  Naunyn-Schmiedeberg's Arch. Pharmacol. 303:55, 1978.

136.        Brown, BS, Polson, JB, Krzanowski, JJ, and Szentivanyi, A:  Dissociation of accentuated negative inotropism and cyclic AMP lowering by methacholine in methylisobutylxanthine-treated rat atria. Federation Proc. 37:476, 1978.

137.        Lowitt, S, Williams, JF, and Szentivanyi, A:  Dexamethasone induction to tryptophan oxygenase activity in vivo and in isolated rat hepatic parenchymal cells:  Effect of bacterial endotoxin. The Pharmacologist 20:157, 1978.

138.        Williams, JF, Lowitt, S, Polson, JB, and Szentivanyi, A:  Pharmacological and biochemical activities of some monomethylxanthine and methyluric acid derivatives of thophylline and caffeine.  Biochem. Pharmacol. 27:1545, 1978.

139.        Polson, JB, Krzanowski, JJ, Goldman, AL, Ebel, TA, and Szentivanyi, A:  Cyclic nucleotide phosphodiesterase activity in patients with reversible and nonreversible airway obstruction.  Adv. Cyclic Nucleotide Res. 9:757, 1978.

140.        Krzanowski, JJ, Polson, JB, Goldman, AL, Ebel, TA, and Szentivanyi, A:  Cyclic nucleotide levels in human lung from patients with bronchospastic airway disease.  Adv. Cyclic Nucleotide Res. 9:767, 1978.

141.        Polson, JB, Krzanowski, JJ, Goldman, AL, and Szentivanyi, A:  Inhibition of human pulmonary phosphodiesterase activity by therapeutic levels of theophylline.  Clin. Exp. Pharmacol. Physiol. 5:553, 1978.

142.        Krzanowski, JJ, Anderson, WH, Polson, JB, and Szentivanyi, A:  Inhibition of the development of histamine tachyphylaxis in canine tracheal smooth muscle by indomethacin.  In:  "Proceedings of the Seventh International Congress of Pharmacology," Pergamon Press, Ltd., Paris, France, 1978, p. 672.

143.        Szentivanyi, A:  The physiopharmacology of adrenergic responses in bronchial asthma.  In: "Proceedings of the Ninth Congress of the International Association of Asthmology," New Orleans, LA, 1978, p. 5.

144.        Szentivanyi, A:  The beta adrenergic approach to the constitutional basis of atopy.  In:  "Proceedings of the Conference on the Physiopathology of the Atopic State," Rosario, Argentina, Arch. Argent. de Alergia e Inmunologia 12:31, 1978.

145.        Szentivanyi, A:  The phenomenon of adrenergic receptor interconversion and its implications to the pathogenesis of atopic disorders.  In:  "Proceedings of the Conference on the Physiopathology of the Atopic State," Rosario, Argentina, Arch. Argent. de Alergia e Inmunologia 12:34, 1978.

146.        Szentivanyi, A:  Separation of drug and disease-induced adrenergic subsensitivity in lymphocytes.  In:  "Proceedings of Conference on the Physiopathology of the Atopic State," Rosario, Argentina, Arch. Argent. de Alergia e Inmunologia 12:39, 1978.

147.        Szentivanyi, A:  Ultimas adquisiciones sobre la fisiopathologia de los beta-receptores.  In:  "Proceedings of the Conference on the Physiopathology of the Atopic State," Rosario, Argentina,  Arch. Argent. de Alergia e Inmunologia 12:44, 1978.

148.        Krzanowski, JJ, Polson, JB, Goldman, AL, Ebel, TA, and Szentivanyi, A:  Reduced adenosine 3',5'-cyclic monophosphate levels in patients with reversible obstructive airways disease.  Clin. Exp. Pharmacol. Physiol. 6:111, 1979.

149.        Lowitt, S, Williams, JF, and Szentivanyi, A:  Endotoxin attenuation of dexamethasone induction of tryptophan oxygenase activity in isolated hepatic parenchymal cells. Dependence upon nonparenchymal cells.  Federation Proc. 38:366, 1979.

150.        Szentivanyi, A, Heim, O, Schultze, P, and Szentivanyi, J:  Hormonally induced changes in adrenergic and cholinergic receptor densities in lymphocytes.  In:  "Proceedings of the Conference on Subcellular Factors in Immunity," The New York Academy of Sciences, New York, NY, 1979, Abstract No. 31.

151.        Anderson, WH, Krzanowski, JJ, Polson, JB, and Szentivanyi, A:  Prostaglandins as mediators of tachyphylaxis to histamine in canine tracheal smooth muscle.  In:  "Proceedings of International Conference on Prostaglandins," Washington, D.C., 1979, Abstract No. 19.

152.        Szentivanyi, A, Heim, O, Schultze, P, and Szentivanyi, J:  Biochemistry of adrenergic and cholinergic receptors in membranes of lymphocytes from patients with atopic dermatitis.  In:  "Proceedings of the International Symposium on Atopic Dermatitis," Oslo, Norway, 1979, p. 5.

153.        Szentivanyi, A, Heim, O, Schultze, P, and Szentivanyi, J:  Reciprocal adrenoceptor shifts in membranes of lymphocytes from patients with atopic dermatitis.  In:  "Proceedings of Dermatological Institute," British Postgraduate Medical Education, University of London, 1979.

154.        Szentivanyi, A, Heim, O, Schultze, P, Polson, JB, and Szentivanyi, J:  The four phases in the experimental analysis of the beta adrenergic theory of the constitutional basis of atopic disorders.  In:  "Proceedings of the Journees d'Enseignement Post-Universitaires d'Allergo-Immunologie," Universite Aix-Marseille, Marseille, France, 1979, Abstract No. 8.

155.        Polson, JB, Krzanowski, JJ, Anderson, WH, Fitzpatrick, DF, Hwang, DPC and Szentivanyi, A: Analysis of the relationship between pharmacological inhibition of cyclic nucleotide phosphodiesterase and relaxation of canine tracheal smooth muscle.  Biochem. Pharmacol. 28:1391, 1979.

156.        Williams, JF, Lowitt, S, and Szentivanyi, A:  Effect of endotoxin and phenobartibal on hemeenzymes of rat liver.  The Pharmacologist 21:232, 1979.

157.        Anderson, WH, Krzanowski, JJ, Polson, JB, and Szentivanyi, A:  Increased synthesis of prostaglandin-like material during histamine tachyphylaxis in canine tracheal smooth muscle. Biochem. Pharmacol. 28:2223, 1979.

158.        Krzanowski, JJ, Polson, JB, and Szentivanyi, A:  Divergent effects of prostaglandin synthesis inhibitors on pulmonary cyclic 3',5'-adenosine monophosphate and cyclic 3',5'-guanosine monophosphate levels in untreated and histamine-sensitized mice.  Arch. Int. Pharmacodyn. 241:324, 1979.

159.        Anderson, WH, Krzanowski, JJ, Polson, JB, and Szentivanyi, A: Characteristics of histaminetachyphylaxis in canine tracheal smooth muscle:  A possible prostaglandin mediated phenomenon.  Naunyn-Schmiedeberg's Arch. Pharmacol. 308:117, 1979.

160.        Szentivanyi, A:  Las cuatro fases en el analisis experimental de la teoria beta-adrenergica en lasenfermedades atopicas.  Parte I.  In:  "Proceedings of the International Symposium on Childhood Asthma in the International Year of the Child," Santiago, Chile, September 5-7, 1979, Abstract No. 8.

161.        Szentivanyi, A:  Las cuatro fases en el analisis experimental de la teoria beta-adrenergica en las enfermedades atopicas.  Parte II.  In:  "Proceedings of the International Symposium on Childhood Asthma in the International Year of the Child," Santiago, Chile, September 5-7, 1979, Abstract No. 9.

162.        Szentivanyi, A:  Nuevas evidencias del bloqueo beta-adrenergico en el origen de la dermatitisatopica.  In:  "Proceedings of the Annual Congress of the Sociedad Chilena de Dermatologia y Venereologia," September 8, 1979.

163.        Polson, JB, Krzanowski, JJ, and Szentivanyi, A:  Stimulation of cyclic AMP phosphodiesterase activity by the heated supernatant fraction of canine tracheal smooth muscle.  Allergol. et Immunopathol. 7:297, 1979.

164.        Williams, JF, Lowitt, S, and Szentivanyi, A:  Effects of phenobarbital and 3-methylcholanthrene pretreatment on the plasma half-life and urinary excretion profile of theophylline and its metabolites in rats.  Biochem. Pharmacol. 28:2935, 1979.

165.        Szentivanyi, A:  The conformational flexibility of adrenoceptors and the constitutional basis of atopy.  Triangle 18:109, 1979.

166.        Szentivanyi, A, Heim, O, and Schultze, P:  Changes in adrenoceptor densities in membranes of lung tissue and lymphocytes from patients with atopic disease.  Ann. N.Y. Acad. Sci. 332:295, 1979.

167.        Szentivanyi, A, Schultze, P, Heim, O, Szentivanyi, J, and Polson, JB:  Two different patterns of adrenoceptor mechanisms in drug versus disease-induced beta adrenergic subsensitivity in membranes of T and B lymphocytes.  J. Reticuloendoth. Soc. 26:291, 1979.

168.        Szentivanyi, A:  La flexibilite de conformation des adrenocepteurs et la base constitutionelle du terrain allergique.  Rev. Franc. Allergol. 19:205, 1979.

169.        Anderson, WH, Krzanowski, JJ, Polson, JB, and Szentivanyi, A:  Prostaglandins as mediators of tachyphylaxis to histamine in canine tracheal smooth muscle. Adv. Prostaglandin Thromboxane Res. 7: 995, 1980.

170.        Szentivanyi, A, and Williams, JF:  The Constitutional Basis of Atopic Disease. Chapter 14.  In:  "Allergic Diseases of Infancy, Childhood, and Adolescence," C.W. Bierman and D.S. Pearlman, eds., W.B. Saunders Co., Philadelphia, PA, 1980, pp. 173-210.

171.        Szentivanyi, A, Szentivanyi, J, and Wagner, H:  Measurement of numbers of adrenoceptors in lymphocytes and lung tissue of patients with reversible obstructive airways disease.  Clin. Pharmacol. Ther. 27:193, 1980.

172.        Szentivanyi, A:  Invited Editorial:  The radioligand binding approach in the study of lymphocytic adrenoceptors and the constitutional basis of atopy.  J. Allergy Clin. Immunol. 65:5, 1980.

173.        Szentivanyi, A, and Szentivanyi, J:  The conformational flexibility of adrenoceptors.  Relationship to cyclic nucleotides and the constitutional basis of atopy.  In:  "Proceedings of Xth International Congress of Allergology," A. Oehling, ed., Pergamon Press, 1980, pp. 31-41.

174.        Szentivanyi, A, and Middleton, Jr., E:  Asthma pharmacotherapy and why.  J. Respirat. Therap. 1:10, 1980.

175.        Szentivanyi, A, Krzanowski, JJ, Polson, JB, Anderson, WH, and Szentivanyi, J:  Regulation of alpha and beta adrenoceptors in health and atopic disease.  In:  "Proceedings of the 36th Annual Congress of the American College of Allergy, Postgraduate Session," Bal Harbour, Fl, Jan. 19-23, 1980.

176.        Anderson, WH, Krzanowski, JJ, Polson, JB, and Szentivanyi, A:  Differences in histamine responsiveness of canine trachea and small airways.  Federation Proc. 39:1094, 1980.

177.        Szentivanyi, A, Polson, JB, and Krzanowski, JJ:  The Altered Reactivity of the Effector Cells to Antigenic and Pharmacological Influences and its Relation to Cyclic Nucleotides. I. Effector Reactivities in the Afferent Loop of the Immune Response.  In:  "Pathomechanismus und Pathogenese Allergischer Reaktionen," G. Filipp, ed., Werk-Verlag, Dr. Edmund Banachewski, Grafelfing bei Munchen, 1980, pp. 460-510.

178.        Szentivanyi, A, and Fitzpatrick, DF:  The Altered Reactivity of the Effector Cells to Antigenic and Pharmacological Influences and its Relation to Cyclic Nucleotides. II. Effector Reactivities in the Efferent Loop of the Immune Response.  In:  "Pathomechanismus und Pathogenese Allergischer Reaktionen," G. Filipp, ed., Werk-Verlag Dr. Edmund Banachewski, Grafelfing bei Munchen, 1980, pp. 511-580.

179.        Szentivanyi, A, Krzanowski, JJ, Polson, JB, and Anderson, WH:  Evolution of Research Strategy in the Experimental Analysis of the Beta Adrenergic Approach to the Constitutional Basis of Atopy.  In:  "Advances in Allergology and Clinical Immunology," A. Oehling, E. Mathov, I. Glazer, and C. Arbesman, eds., Pergamon Press, Oxford, 1980, pp. 301-308.

180.        Anderson, WH, Krzanowski, JJ, Polson, JB, and Szentivanyi, A:  Prostaglandin E2 inhibits histmaine-stimulated calcium influx in canine tracheal smooth muscle.  J. Allergy Clin. Immunol. 65:237, 1980.

181.        Krzanowski, JJ, Anderson, WH, Polson, JB, and Szentivanyi, A:  Histamine tachyphylaxis in primate tracheal smooth muscle.  Federation Proc. 39:297, 1980.

182.        Szentivanyi, A:  The influence of glucocorticosteroids on the system of alpha and beta adrenoceptors.  In:  "Proceedings of the International Symposium of Glucocorticoids," G. Kunkel, ed., West Berlin, Germany, Allergie Suppl. 1, 1980.

183.        Williams, JF, Lowitt, S, and Szentivanyi, A:  Involvement of a heat-stable and heat-labile component of Bordetella pertussis in the depression of murine hepatic mixed-function oxidase system.  Biochem. Pharmacol. 29:1483, 1980.

184.        Hackney, JF, and Szentivanyi, A:  Response of isolated guinea pig tracheal muscle to glucocorticoid and non-glucocorticoid succinates.  Arch. Int. Pharmacodyn. Therap. 244:4, 1980.

185.        Fitzpatrick, DF, and Szentivanyi, A:  Myogenic tone and hyporesponsiveness of vascular smooth muscle of spontaneously hypertensive rats.  The Pharmacologist 22:163, 1980.

186.        Szentivanyi, A:  a. The Conformational Flexibility of Adrenoceptors and the Constitutional Basis of Atopy.  In:  "Asthma Series 2," R. Schindler, ed., Sandoz Publications, Basel, Switzerland, 1980, pp. 8-15.  b. Die Flexibilitat in der Konfiguration der Adrenorezeptoren und die konstitutionnelle Grundlage der Atopie.  In:  "Asthma-Serie 2," R. Schindler, ed., Sandoz-Publikation, Basel, 1980, pp. 8-15.  c. Variations de Structure des Adrenorecepteurs et bases constitutionelles de l'atopie.  In:  "Serie sur L'asthme 2," R. Schindler, ed., Sandoz, Basel, 1980, pp. 8-15.

187.        Szentivanyi, A:  University of South Florida College of Medicine - A status report.  J. Florida Med. Soc. 67:921, 1980.

188.        Szentivanyi, A:  Homeostatic regulation of receptor densities on effector cell membranes.  In:  "Proceedings of Symposium on Selective Aspects of the Pharmacology of the Reticuloendothelial System," XVII National Reticuloendothelial Society Meeting, Tampa, FL, 1980.

189.        Williams, JF, Lowitt, S, and Szentivanyi, A:  Endotoxin depression of hepatic mixed function oxidase system in C3H/Hej and C3H/H3N mice.  Int. J. Immunopharmacology 2:285, 1980.

190.        Szentivanyi, A, Heim, O, Schultze, P, and Szentivanyi, J:  Adrenoceptor binding studies with [3H] dihydroalprenolol with [3H] dihydroergocryptine on membranes of lymphocytes from patients with atopic disease.  Acta. Dermato-Venereol. Suppl. 92:19, 1980.

191.        Fitzpatrick, DF, and Szentivanyi, A:  Calcium-dependent increase in myogenic tone in vascular smooth muscle of spontaneously hypertensive rats.  Clin. Exp. Hypertension 2:1023, 1980.

192.        Krzanowski, JJ, Anderson, WH, Polson, JB, and Szentivanyi, A:  Prostaglandin mediated histamine tachyphylaxis in subhuman primate tracheal smooth muscle.  Arch. Int. Pharmacodyn. Therap. 247:155, 1980.

193.        Krzanowski, JJ, Anderson, WH, Polson, JB, and Szentivanyi, A:  Cyclic nucleotide profiles in canine tracheal smooth muscle during development of histamine tachyphylaxis.  In:  "Proceedings of Adrenergic Receptor Pharmacology Symposium," Trans. Southeast Pharmacol. Soc. 1:24, 1980.

194.        Krzanowski, JJ, Asai, S, Anderson, WH, Martin, D, Lockey, R, Bukantz, S and Szentivanyi, A:  Contractile effects of Ptychodiscus brevis toxin on canine airways smooth muscle.  Federation Proc. 40:721, 1981.

195.        Polson, JB, Krzanowski, JJ, and Szentivanyi, A:  Separation of the cyclic nucleotide phosphodiesterase of canine tracheal smooth muscle.  Federation Proc. 40:665, 1981.

196.        Szentivanyi, A:  Adrenoceptor response in disorders of atopic allergy.  In:  "Proceedings of the International Symposium on Cellular and Humoral Responses in Allergic Disease," Montreal, Quebec, Canada, 1981, pp. 184-193.

197.        Szentivanyi, A, and Szentivanyi, J:  The role of chalons and beta adrenergic receptors in dermatological pathology.  In:  "Proceedings of the XIII International Congress of Dermatology," Budapest, Hungary, 1981, pp. 29-37.

198.        Szentivanyi, A, and Szentivanyi, J:  Adrenergic regulation of cyclic AMP-mediated functions of mast cells and lymphocytes.  In:  "Proceedings of International Symposium on Drug Hypersensitivity," Rosario, Argentina, 1981, pp. 64-82.

199.        Szentivanyi, A:  Regulation of adrenergic and cholinergic receptor concentrations on effector cell membranes and the problem of bronchial hypersensitivity in asthma.  In:  "Proceedings of Fison International Symposium:  Update on Bronchial Hyperreactivity," Washington, D.C., 1981, p. 9.

200.        Szentivanyi, A, and Szentivanyi, J:  New concepts on beta adrenoceptors in the allergic diathesis.  In:  "Proceedings of the XXXVII Annual Congress of the American College of Allergists," Washington, D.C., 1981, p. 22.

201.        Krzanowski, JJ, Anderson, WH, Polson, JB, and Szentivanyi, A:  Cyclic nucleotide levels during the developmet of histamine tachyphylaxis in canine smooth muscle.  The Pharmacologist 23:226, 1981.

202.        Lowitt, S, Szentivanyi, A, and Williams, JF:  Endotoxin inhibition of dexamethasone induction of tryptophan oxygenase in suspension culture of isolated rat parenchymal cells. I. Involvement of the hepatic nonparenchymal cell fraction.  Biochem. Pharmacol. 30:1999, 1981.

203.        Williams, JF, Winters, AL, Lowitt, S, and Szentivanyi, A:  Depression of hepatic mixed-function oxidase activity by Bordetella pertussis in splenectomized and athymic nude mice.  Immunopharmacology 3:101, 1981.

204.        Szentivanyi, A:  The birth of a medical school--an act of creation.  J. Fla. Med. Assoc. 68:705, 1981.

205.        Szentivanyi, A and Szentivanyi, J:  Role of the sympathetic nervous system in asthma.  In: "Proceedings of the Xth Interasma Congress," Paris, France, 1981, p. 16.

206.        Szentivanyi, A, and Szentivanyi, J:  Anti-allergic drugs and beta adrenoceptors.  In:  "Proceedings of the Congress of the European Academy of Allergology and Clinicial Immunology," Clermont-Ferrand, France, 1981, p. 104.

207.        Asai, S, Krzanowski, JJ, Anderson, W, Martin, D, Lockey, RF, Bukantz, SC and Szentivanyi, A:  Effects of the toxin of red tide, Ptychodiscus bevis on canine tracheal smooth muscle.  In:  "Proceedings of the XXXVII Annual Meeting of the American Academy of Allergy," San Francisco, CA, 1981, p. 20.

208.        Kirkman, L, Goldman, A, Krzanowski, JJ, Polson, JB, Anderson, W, Richman, A, and Szentivanyi, A:  Enhanced  in vitro sensitivity to propranolol-induced beta adrenergic blockade in COPD patients.  Amer. Rev. Resp. Dis. 123(2):79, 1981.

209.        Szentivanyi, A:  Effects of corticosteroids on the airways in health and disease.  In:  "Proceedings of the Congress of the European Academy of Allergology and Clinical Immunology," Clermont-Ferrand, France, 1981, p. 149.

210.        Szentivanyi, A:  El papel del sistema simpatico en el asma.  In:  "Proceedings of the VII Colloquy on Immunology and Allergology," Pamplona, Spain, 1981, p. 5.

211.        Szentivanyi, A, and Szentivanyi, J:  Role of the sympathetic nervous system in asthma.  Respiration 42(Suppl. 1):3, 1981.

212.        Szentivanyi, A:  The basic and clinical pharmacology of histamine receptors.  In:  "Proceedings of the International Symposium on Recent Aspects of the Role of Histamine in Immunologic Inflammation," College de France, Paris, France, 1982, pp. 131-142.

213.        Polson, JB, Krzanowski, JJ, Anderson, WH, and Szentivanyi, A:  Effects of ketotifen, a benzocycloheptathiophene, on methacholine- and acetylcholine-induced contractions of canine respiratory smooth muscle.  Immunopharmacology 4:69, 1982.

214.        Asai, S, Krzanowski, JJ, Martin, DF, Lockey, RF, Bukantz, SC, and Szentivanyi, A:   Ptychodiscus brevis toxin stimulates a new receptor site in activating parasympathetic nerve axonal voltage-sensitive sodium channels.  J. Allergy Clin. Immunol. 69(Suppl.):10, 1982.

215.        Krzanowski, JJ, Asai, S, Martin, DF, Lockey, RF, Bukantz, SC, and Szentivanyi, A:  Effects of the imported fire ant (Solenopsis invicta) venom on canine tracheal smooth muscle contraction induced by axonal sodium channel stimulators (Ptychodiscus brevis toxin, veratridine, and scorpion toxin).  J. Allergy Clin. Immunol. 69(Suppl.):105, 1982.

216.        Szentivanyi, A:  Adrenergic and Cholinergic Receptor Studies in Human Lung and Lymphocytic Membranes and Their Relation to Bronchial Hyperreactivity in Asthma.  In:  "Patient Care Publications," Darien, CT, 1982, pp. 16-19.

217.        Szentivanyi, A:  Bases constitucionales de la atopia. Evolucion de la investigacion en el analisis experimental de la teoria beta-adrenergica.  Archives of the Royal Spanish Academy of Medicine, 1982.

218.        Williams, JF, and Szentivanyi, A:  Possible involvement of alpha adrenergic mechanisms and reticuloendothelial activation in the effects of bacterial lipopolysaccharide on hepatic enzyme activities.  Federation Proc. 41:1722, 1982.

219.        Szentivanyi, A:  Histamine protonation and tautomerism.  In:  "Proceedings of the New York Academy of Sciences Symposium on Cell Surface Receptors," New York, NY, 1982, pp. 94-102.

220.        Szentivanyi, A, and Szentivanyi, J:  New aspects of receptor behavior in atopy.  In:  "Proceedings of the Kongress der arztlichen Arbeitsgemeinschaft fur angewandte Allergologie," Acron Verlag Manfred Bolschakoff, West Berlin, Federal Republic of Germany, 1982, pp. 4-7.

221.        Polson, JB, Krzanowski, JJ, Goldman, AL, and Szentivanyi, A:  Cyclic nucleotide phosphodiesterase activity in patients with obstructive airways disease.  Allergol. et Immunopathol. 10:101, 1982.

222.        Asai, S, Krzanowski, JJ, Anderson, WH, Martin, DF, Polson, JB, Lockey, RF, Bukantz, SC, and Szentivanyi, A:  Effects of the toxin of red tide, Ptychodiscus brevis, on canine tracheal smooth muscle. A possible new asthma-triggering mechanism.  J. Allergy Clin. Immunol. 69:418, 1982.

223.        Szentivanyi, A:  Adrenergic receptors.  Int. J. Immunopharmacol. 4:292, 1982.

224.        Polson, JB, Krzanowski, JJ, and Szentivanyi, A:  Inhibition of a high affinity cyclic AMP phosphodiesterase and relaxation of canine tracheal smooth muscle.  Biochem. Pharmacol. 31:3403, 1982.

225.        Szentivanyi, A, and Szentivanyi, J:  Altered Adrenoceptor Function in Disease States.  In: "Adrenoceptors and Catecholamine Actions," G. Kunos, ed., Volume 2, John Wiley and Sons, Inc. 1982.

226.        Szentivanyi, A, and Szentivanyi, J:  Immunomodulatory effects of central and peripheral autonomic mechanisms mediated by neuroeffector molecules.  In:  "Proceedings of International Symposium on Biological Response Modifiers in Clinical Oncology and Immunology," Tampa, FL, 1982, p. 8.

227.        Szentivanyi, A, and Szentivanyi, J:  The acquired and genetically altered reactivity to the chemical organizers of autonomic action as the constitutional basis of atopy.  In:  "Proceedings of the Plenary Symposium on Asthma and Research. XIth International Congress of Allergology and Clinical Immunology," London, England, 1982, pp. 204-212.

228.        Szentivanyi, A, and Szentivanyi, J:  The reciprocal counterregulatory interplay between alpha and beta adrenoceptors and its relation to induced changes in receptor specificity.  In:  "Proceedings of the XIth International Congress of Allergology and Clinical Immunology," London, England, 1982, pp. 328-341.

229.        Szentivanyi, A, and Szentivanyi, J:  Measurement of cholinergic, beta adrenergic, and alpha adrenergic receptor subtype in atopic disorders with the radioligand binding technique.  In:  "Proceedings of the First International Meeting on Bronchial Asthma," Instituto Argentino de Alergia e Inmunologia, Mar del Plata, Argentina, 1982, pp. 173-191.

230.        Szentivanyi, A, and Szentivanyi, J:  Three different mechanisms in the corticosteroid-induced potentiation of adrenoceptor reactivities.  In:  "Proceedings of Schering Lecture Series," West  Berlin, Federal Republic of Germany, 1982, pp. 154-159.

231.        Szentivanyi, A:  Clinical pharmacology of beta adrenergic blockade in bronchial asthma.  In:  "Proceedings of Ist Interamerican Congress of Clinical Pharmacology and Therapeutics," Caracas,  Venezuela, 1982, pp. 27-43.

232.        Szentivanyi, A:  Introduction and some reflections on the significance of medical history in diseases of atopic allergy.  In:  "Proceedings of the Symposium on Medical Applications in Microcomputers," Tampa, FL, 1982, pp. 1-4.

233.        Szentivanyi, A, and Szentivanyi, J:  The emergence of neuroendocrine disorders as a new group of autoimmune diseases.  In:  "Proceedings of the Symposium on Clinical Laboratory Immunology," Clearwater, FL, 1982, p. 3.

234.        Szentivanyi, A, and Szentivanyi, J:  Einfluss von Ketotifen auf das adrenerge Effektrosystem.  Wander Publications, Nurnberg, West Germany, 1982, Part 1, p. 5.

235.        Szentivanyi, A, and Szentivanyi, J:  Receptor dynamics in atopic allergy.  In:  "Proceedings of the International Conference of the Nederlands Astma Fonds," Utrecht, The Netherlands, 1982, p. 38.

236.        Williams, JF, and Szentivanyi, A:  Continued studies on the effect of interferon inducers on the hepatic microsomal mixed-function oxidase system of rats and mice.  In:  "Proceedings of the Second International Congress for Interferon Research," Miami, FL, 1982, p. 7.

237.        Szentivanyi, J, and Szentivanyi, A:  The significance of the cutaneous basophil hypersensitivity syndrome in clinical medicine.  In:  "Proceedings of the International Symposium on Basic and Clinical Aspects of Immunologically Induced Cutaneous Inflammatory Reactions," Caracas, Venezuela, 1982, pp. 73-85.

238.        Szentivanyi, A, and Szentivanyi, J:  Altered adrenoceptor function in disease states.  Pathobiol. Annu. 12:340, 1982.

239.        Lowitt, S, Szentivanyi, A, and Williams, JF:  Endotoxin inhibition of dexamethasone induction of tryptophan oxygenase in suspension culture of isolated rat parenchymal cells. II. Effect of in vivo pretreatment of rats with endotoxin.  Biochem. Pharmacol. 31:693, 1982.

240.        Szentivanyi, A:  Cancer, aging, mental health, and immunobiology in our research development. J. Fla. Med. Assoc. 70:126, 1983.

241.        Krzanowski, JJ, Polson, JB, McPherson, M, Urdaneta-Bohorquez, A, and Szentivanyi, A:  Adenosine-theophylline interactions in canine tracheal smooth muscle strips.  J. Allergy Clin. Immunol. 71:131, 1983.

242.        Polson, JB, Krzanowski, JJ, and Szentivanyi, A:  Cyclic nucleotide phosphodiesterases partially purified from canine tracheal smooth muscle.  In:  "Proceedings of the Lorenzini Foundation Symposium on Cyclic Nucleotides and Protein Phosphorylation," Universita Degli Studi di Milano, Supplemento 32, 1983, p. 41.

243.        Williams, JF, and Szentivanyi, A:  Effect of endotoxin on endotoxin-tolerant animals on mixed-function oxidase and heme-oxygenase activities.  The Pharmacologist 25:218, 1983.

244.        Szentivanyi, A, and Szentivanyi, J:  Neuester Stand der Rezeptoren-Theorie bei Atopie.  Allergologie 6:155, 1983.

245.        Anderson, WH, Krzanowski, JJ, Polson, JB, and Szentivanyi, A: The effect of prostaglandin E2 on histamine-stimulated calcium mobilization as a possible explanation for histamine tachyphylaxis in canine tracheal smooth muscle.  Naunyn-Schmiedeberg's Arch. Pharmacol. 322:72, 1983.

246.        Szentivanyi, A, and Szentivanyi, J:  Some selected aspects of the immunopharmacology of adrenoceptors.  Adv. in Immunopharmacol. 2:269, 1983.

247.        Szentivanyi, J, and Szentivanyi, A:  An update on the nature of the constitutional factor in the pathogenesis of atopic dermatitis.  In:  "Proceedings of the XVI International Congress of Dermatology," Tokyo, Japan, 1983, p. 74.

248.        Szentivanyi, J, and Szentivanyi, A:  Mechanisms of interactions between corticosteroids and catecholamines.  In:  "Proceedings of the First International Meeting on Bronchial Asthma," Instituto Argentino de Alergia e Inmunologia, Mar del Plata, Argentina, 1983, pp. 208-223.

249.        Szentivanyi, A, and Szentivanyi, J:  Current curricular trends in the medical schools of the United States.  In:  "Proceedings of International Conference on Opportunities in Medicine," Aspira, Inc. de Puerto Rico, San Juan, Puerto Rico, 1983, pp. 31-49.

250.        Klein, TW, Specter, S, Friedman, H, and Szentivanyi, A:  Biological response modifiers in human oncology and immunology.  Adv. Exper. Med. Biol. 166:315, 1983.

251.        Szentivanyi, A, Krzanowski, JJ, and Polson, JB:  The Autonomic Nervous System.  In:  "Allergy:  Principles and Practice," E. Middleton, C.E. Reed, and E.F. Ellis, eds., Second Edition, The C.V. Mosby Co., St. Louis, MO, 1983, pp. 303-331.

252.        Szentivanyi, A, Middleton, E, Williams, JF, and Friedman, H:  Effect of microbial agents on the immune network and associated pharmacologic reactivities.  In:  "Allergy:  Principles and Practice," E. Middleton, C.E. Reed, and E.F. Ellis, eds., Second Edition, The C.V. Mosby Co., St. Loui, MO, 1983, pp. 211-236.

253.        Krzanowski, JJ, Urdaneta-Bohorquez, A, Polson, JB, Sakamoto, Y, and Szentivanyi, A:  Studies of two smooth muscle relaxants (adrenosine and theophylline) both capable of influencing tissue cyclic AMP levels in canine tracheal smooth muscle.  In:  "The Lorenzini Foundation Symposium on Cyclic Nucleotides and Protein Phosphorylation," Universita' Degli Studi di Milano, Supplemento 32, 1983, p. 49.

254.        Williams, JF, and Szentivanyi, A:  Continued studies on the effect of interferon inducers on the hepatic microsomal mixed-function oxidase system of rats and mice.  J. Interferon Res. 3:211, 1983.

255.        Szentivanyi, A:  The role and significance of research in the modern medical curriculum.  Huellas, Universidad del Norte, Barranquilla, Colombia, 1983, pp. 14-27.

256.        Szentivanyi, A:  Another look at the Hippocratic oath.  J. Fla. Med. Assoc. 70:658, 1983.

257.        Williams, JF, and Szentivanyi, A:  Investigation of adrenergic and prostaglandin influences in the endotoxin alteration of hepatic hemeoxygenase, microsomal mixed-function oxidase, and glucocorticoid-induced tryptophan oxygenase activities.  Immunopharmacology 6:75, 1983.

258.        Szentivanyi, A, and Szentivanyi, J:  The pathogenesis of respiratory and cutaneous atopy. In:  "Proceedings of the Annual Congress of the Hungarian Society for Allergy and Clinical Immunology," Szeged, Hungary, 1983, p. 9.

259.        Szentivanyi, A, and Szentivanyi, J:  Dynamics of lymphocytic membrane receptors of the chemical organizers of autonomic action in disorders of atopic allergy.  In:  "Proceedings of International Symposium on Signal and Signal Processing in the Immune System:  Non-antigen Receptors," Balatonfured, Hungary, 1983, p. 59.

260.        Szentivanyi, A, and Szentivanyi, J:  Biochemical Mechanisms of Beta Adrenergic Subsensitivity in Asthma and Atopic Dermatitis.  In:  "Clinical Pharmacology and Therapeutics," M. Velasco, ed., Elsevier Science Publishers, New York, NY, 1983, pp. 291-296.

261.        Krzanowski, JJ, and Szentivanyi, A:  Invited Editorial:  Reflections on some aspects of current research in asthma.  J. Allergy Clin. Immunol. 72:433, 1983.

262.        Szentivanyi, A, and Szentivanyi, J:  Receptors on lymphocytes modulating immune response. In:  "Proceedings of the Third International Sanrocco Symposium," Menaggio, Italy, 1983, p. 23.

263.        Szentivanyi, A:  An experiment in the study of human values in medicine.  J. Fla. Med. Assoc. 70:1029, 1983.

264.        Szentivanyi, J, and Szentivanyi, A:  Atopic dermatitis.  Progres en dermatologie, Editions Hippocrates Paris, Paris, France, 1983, pp. 532-541.

265.        Szentivanyi, J, and Szentivanyi, A:  A comparative analysis of phosphorylation processes in induced and spontaneous adrenergic subsensitivities of lymphocytes derived from normal individuals and atopic dermatitis patients.  In:  "Proceedings of Second International Symposium on Atopic Dermatitis, "Trondheim, Norway, 1983, pp. 9-14.

266.        Szentivanyi, A:  Ionic and tautomeric equilibria between histamine species and their relation to histamine conformation.  In:  "Proceedings of International Symposium on Receptor Biology,"National Institutes of Health, Bethesda, MD, 1983, pp. 157-163.

267.        Szentivanyi, A, Polson, JB, and Szentivanyi, J:  Issues of adrenoceptor behavior in respiratory and cutaneous disorders of atopic allergy.  Trends in Pharmac. Sci. 5:280, 1984.

268.        Sakamoto, Y, Krzanowski, JJ, Lockey, RF, Polson, JB, and Szentivanyi, A:  The mechanism of ergonovine-induced airway smooth muscle contraction.  The Pharmacologist 26:152, 1984.

269.        Asai, S, Krzanowski, JJ, Lockey, RF, Anderson, WH, Martin, DF, Polson, JB, Bukantz, SC, and Szentivanyi, A:  The site of action of Ptychodiscus brevis toxin within the parasympathetic axonal sodium channel h gate in airway smooth muscle.  J. Allergy Clin. Immunol. 73:824, 1984.

270.        Polson, JB, Krzanowski, JJ, and Szentivanyi, A:  Cyclic nucleotide phosphodiesterases partially purified from canine tracheal smooth muscle.  Adv. Cyclic Nucleotide Res. 17A:41, 1984.

271.        Krzanowski, JJ, Urdaneta-Bohorquez, A, Polson, JB, Sakamoto, Y, and Szentivanyi, A:  Studies of two smooth muscle relaxants (adenosine and theophylline) both capable of influencing tissue cyclic AMP levels on canine tracheal smooth muscle.  Adv. Cyclic Nucleotide Res. 17A:49, 1984.

272.        Sakamoto, Y, Krzanowski, JJ, Lockey, RF, Polson, JB, and Szentivanyi, A:  The potential of ergonovine to precipitate bronchial asthmatic attacks via serotonin receptors.  J. Allergy Clin. Immunol. 73:129, 1984.

273.        Friedman, H, Klein, T, Specter, S, and Szentivanyi, A:  Immunomodulation induced by microorganisms and their products:  relationship to inflammation.  In:  "Proceedings of Ist World Conference on Inflammation, Antirheumatics, Analgesics, and Immunomodulators," Venice, Italy, 1984, pp. 182-183.

274.        Szentivanyi, J, Szentivanyi, A, Williams, J, and Friedman, H:  Virus associated immune and pharmacologic mechanisms in disorders of respiratory and cutaneous atopy.  In:  "Proceedings of International Symposium on Viruses, Immunity, and Immunodeficiency," Tampa, FL, 1984, p. 11.

275.        Zhang, J-L, Friedman, F, Hsu, L, Specter, S, Friedman, H, Nonoyama, M, and Szentivanyi, A: Epstein-Barr virus induced lymphoma cells suppress peripheral blood mitogenic responsiveness in vitro.  In:  "Proceedings of International Symposium on Viruses, Immunity and Immunodeficiency," Tampa, FL, 1984, p. 8.

276.        Szentivanyi, A, and Szentivanyi, J:  Cellular and Molecular Foundations of Immunity, Immunologic Inflammation and Hypersensitivity.  Component Parts and Their Relation to Neurohumoral Control Mechanisms.  In:  "Sodeman's Pathologic Physiology - Mechanisms of Disease," W.A. Sodeman and T.M. Sodeman, eds., Seventh Edition, W.B. Saunders Co., Philadelphia, PA, 1985, pp. 113-150.

277.        Szentivanyi, A, and Szentivanyi, J:  The Pathophysiology of Immunologic and Related Diseases.  In:  "Sodeman's Pathologic Physiology - Mechanisms of Disease," W.A. Sodeman and T.M. Sodeman,  eds., Seventh Edition, W.B. Saunders Co., Philadelphia, PA, 1985, pp. 151-197.

278.        Szentivanyi, A, Polson, JB, and Szentivanyi, J:  Adrenergic Regulation.  In:  "Bronchial Asthma:  Mechanisms and Therapeutics," E.B. Weiss, M.S. Segal, and M. Stein, eds., Little, Brown and Co., Boston, MA, 1985, pp. 126-150.

279.        Williams, JF, and Szentivanyi, A:  Pharmacokinetic and Pharmacodynamic Parameters Affected by RE Cell Activators.  In:  "The Pharmacology of the Reticuloendothelial System," J.W. Hadden and A. Szentivayi, eds., Volume V, Plenum Press, New York, NY, 1985, pp. 1-26.

280.        Friedman, H, and Szentivanyi, A:  Microbial vaccines - specific and non-specific modifiers of immunity.  Immunology and Allergy Practice 7:40/17, 1985.

281.        Polson, JB, Krzanowski, JJ, and Szentivanyi, A:  Correlation between inhibition of a cyclic GMP phosphodiesterase and relaxation of canine tracheal smooth muscle.  Biochem. Pharmacol. 34:1875, 1985.

282.        Sakamoto, Y, Krzanowski, JJ, Lockey, RF, Martin, D, Duncan, R, Polson, JB, and Szentivanyi, A:  The mechanism of Ptychodiscus brevis toxin induced rat vas deferens contraction.  J. Allergy Clin. Immunol. 76:117, 1985.

283.        Williams, JF, and Szentivanyi, A:  Effect of carbon tetrachloride on hepatic cytochrome P-450 activity in endotoxin tolerant and polymixin B treated rats.  The Pharmacologist 27:251, 1985.

284.        Szentivanyi, A, and Szentivanyi, J:  The interaction of bacterial components with cell surface receptors.  In:  "Proceedings of International Symposium on Immunomodulation," Stichting Studiecentrum voor Allergie-Projecten, Haarlem, The Netherlands, 1985, pp. 231-253.

285.        Williams, JF, and Szentivanyi, A:  Induction of tolerance in mice and rats to the effect of endotoxin to decrease the hepatic microsomal mixed-function oxidase system.  Evidence for a possible macrophage-derived factor in endotoxin effect.  Int. J. Immunopharmacol. 7:501, 1985.

286.        Szentivanyi, A:  The conformational properties of the histamine molecule based on nuclear magnetic resonance spectroscopy, x-ray crystallography, and theoretical calculations.  In:  "Proceedings of Smith, Kline, and French International Symposium on the Biochemical Pharmacology of Inflammation," Lima, Peru, 1985, pp. 97-125.

287.        Szentivanyi, A:  Catecholamines, adrenoceptors, and anti-receptor antibodies.  In:  "Proceedings of Smith, Kline, and French International Symposium on the Biochemical Pharmacology of Inflammation," Lima, Peru, 1985, pp. 126-142.

288.        Szentivanyi, A, and Szentivanyi, J:  Mechanisms of action of corticosteroids.  In:  "Proceedings of the International Symposium on Allergy and Immunology," Lima, Peru, 1985, pp. 227-241.

289.        Szentivanyi, A:  The biochemistry of cyclic nucleotide phosphodiesterase inhibition as it relates to the clinical pharmacology of asthma.  In:  "Proceedings of the First Purdue Frederick Symposium on Methylxanthine Therapy," Boca Raton, FL, 1985.

290.        Friedman, H, and Szentivanyi, A:  Antibacterial immunity, vaccines, and allergy.  Allergologie 8:357, 1985.

291.        Szentivanyi, A, and Szentivanyi, J:  Drug receptors and cyclic nucleotides in allergy.  In:  "Proceedings of the Alfred Benzon Symposium on Dynamic Processes in Membranes and Cells Versus the Drug Receptor Concept," Copenhagen, Denmark, 1985, pp. 272-283.

292.        Szentivanyi, A:  The pharmacological aspects of endotoxin actions.  In:  "Proceedings of International Symposium on Immunomodulation by Endotoxin and Its Fragments," Jerusalem, Israel, 1985, pp. 17-31.

293.        Szentivanyi, A, and Szentivanyi, J:  Beta adrenergic receptors.  In: "Proceedings of the International Symposium on Allergy and Immunology," Lima, Peru, 1985, pp. 114-127.

294.        Friedman, H, and Szentivanyi, A:  Interaction of bacteria with lymphocytes and the murine response mechanism.  In:  "Proceedings of International Symposium on Bacteria and the Host," Prague, Czechoslovakia, 1985, p. 9.

295.        Friedman, H, and Szentivanyi, A:  Immunomodulation induced by bacterial endotoxins and split product derivatives.  In:  "Proceedings of International Symposium on Immunomodulation by Endotoxin and Its Fragments," Jerusalem, Israel, 1985, p. 16.

296.        Friedman, H, Nowotny, A, and Szentivanyi, A:  Enhanced immune responsiveness of leukemia virus infected splenocytes by nontoxic bacterial polysaccharide-rich preparations.  In:  "Proceedings of International Symposium on Bacteria and the Host," Prague, Czechoslovakia, 1985, p. 12.

297.        Filipp, G, and Szentivanyi, A:  Anaphylaxis and the Nervous System. Part III.  In:  "Foundations of Psychoneuroimmunology," S. Locke, R. Ader, H.O. Besedovsky, N.R. Hall, G. Solomon, and T. Strom, eds., Aldine Publishing Co., Hawthorne, NY, 1985, pp. 1-12.

298.        Szentivanyi, A:  Citation Classic:  Szentivanyi, A, The beta adrenergic theory of the atopic abnormality in bronchial asthma, J. Allergy 42:203-232, 1968.  Current Contents, Life Sciences 28:21, 1985.

299.        Sakamoto, Y, Krzanowski, JJ, Lockey, RF, Duncan, R, Polson, JB, and Szentivanyi, A:  The mechanism of ergonovine-induced airway smooth muscle contraction.  J. Allergy Clin. Immunol. 77:354, 1986.

300.        Szentivanyi, A, and Friedman, H:  Introduction and Historical Perspectives.  In:  "Viruses, Immunity, and Immunodeficiency," A. Szentivanyi and H. Friedman, eds., Plenum Press, New York, NY, 1986, pp. 1-5.

301.        Friedman, H, Szentivanyi, A, Specter, S, and Bendinelli, M:  Virus Interactions with the Immune System.  In:  "Viruses, Immunity, and Immunodeficiency," A. Szentivanyi and H. Friedman, eds., Plenum Press, New York, NY, 1986, pp. 25-39.

302.        Zhang, J-L, Hsu, L, Specter, S, Friedman, H, Nonoyama, M, and Szentivanyi, A:  Depressive Effect of Epstein-Barr Virus Transformed Cell Fractions on Responsiveness of Human Leukocytes to Mitogens.  In:  "Viruses, Immunity, and Immunodeficiency," A. Szentivanyi and H. Friedman, eds., Plenum Press, New York, NY, 1986, pp. 49-58.

303.        Szentivanyi, J, Szentivanyi, A, Williams, JF, and Friedman, H:  Virus Associated Immune and Pharmacologic Mechanisms in Disorders of Respiratory and Cutaneous Atopy.  In:  "Viruses, Immunity, and Immunodeficiency," A. Szentivanyi and H. Friedman, eds., Plenum Press, New York, NY, 1986, pp. 211-244.

304.        Szentivanyi, A, Polson, JB, Szentivanyi, J, and Williams, JF:  Constitutional Factors in Atopic Disease.  In:  "Allergic Diseases of Infancy, Childhood, and Adolescence," C.W. Bierman and D.S. Pearlman, eds., Second Edition, W.B. Saunders Co., Philadelphia, PA, 1986.

305.        Szentivanyi, A, and Friedman, H:  The Biology and Physiopharmacology of Bacterial Lipopolysaccharide Endotoxins and Their Role in Immunoregulation - An Introductory Preview.  In:  "The Immunobiology and Immunopharmacology of Bacterial Endotoxins. Basic and Clinical Aspects," A. Szentivanyi, H. Friedman, and A. Nowotny, eds., Plenum Press, New York, NY, 1986, pp. 3-12.

306.        Williams, JF, and Szentivanyi, A:  Effects of Endotoxin on Mixed Function Oxidase Activity.  In:  "The Immunobiology and Immunopharmacology of Bacterial Endotoxins. Basic and Clinical Aspects," A. Szentivanyi, H. Friedman, and A. Nowotny, eds., Plenum Press, New York, NY, 1986, pp. 159-170.

307.        Friedman, H, and Szentivanyi, A:  Endotoxin and Polysaccharide Derivative-Induced Enhanced Antibody Formation in Leukemia Virus Infected Mice.  In:  "The Immunobiology and Immunopharmacology of Bacterial Endotoxins," A. Szentivanyi, H. Friedman, and A. Nowotny, eds., Plenum Press, New York, NY, 1986, pp. 479-490.

308.        Friedman, H, Klein, T, Szentivanyi, A, and Nowotny, A:  Immunomodulation by bacterial products:  Role of intermediary soluble factors.  Int. J. Immunotherapy 2(1):6164, 1986.

309.        Szentivanyi, A:  The Flexner report and the issue of faculty roles.  J. Fla. Med. Assoc. 73:796, 1986.

310.        Robicsek, S, Polson, JB, Krzanowski, JJ, Lockey, RF, and Szentivanyi, A:  Separation of lymphocyte cyclic nucleotide phosphodiesterases by ion exchange high pressure liquid chromatography. In:  "Proceedings of VIth International Conference on Cyclic Nucleotides, Calcium, and Protein Phosphorylation. Signal Transduction in Biological Systems," National Institutes of Health, Bethesda, MD, 1986, Abstract No. 24.

311.        Friedman, H, Klein, T, Widen, R, and Szentivanyi, A:  Legionella pneumophila-induced enhanced antibody formation in Friend leukemia virus immunosuppressed mice.  In:  "Proceedings of the XIV International Cancer Congress," Budapest, Hungary, 1986.

312.        Friedman, H, Szentivanyi, A, and Nowotny, A:  Immunorestorative effects of endotoxin preparations on lymphocytes from leukemic animals with acquired immunodeficiency.  In:  "Proceedings of XIV International Cancer Congress," Budapest, Hungary, 1986.

313.        Friedman, H, Klein, TW, Nowotny, A, Blanchard, DK, Stewart II, W, and Szentivanyi, A:  Lipopolysaccharide-induction of gamma interferon production.  In:  "Proceedings of International Symposium on Endotoxin:  Structural Aspects and Immunobiology of Host Responses," Bari, Italy, 1986.

314.        Szentivanyi, A, and Williams, JF:  Endotoxin-induced adrenergic modulation.  In:  "Proceedings of International Symposium on the Immunobiology and Immunopharmacology of Bacterial Endotoxins. Basic and Clinical Aspects," Tampa, FL, 1986.

315.        Williams, JF, and Szentivanyi, A:  Endotoxins and the hepatic mixed function oxidase system.  In:  "Proceedings of the International Symposium on the Immunobiology and Immunopharmacology of Bacterial Endotoxins. Basic and Clinical Aspects," Tampa, FL, 1986.

316.        Szentivanyi, A:  Interaction of bacteria and their products with pharmacologic receptors on lymphocytes.  In:  "Proceedings of Southeastern Branch of the American Society of Microbiology Symposium on Modulation of Immune Responses by Bacterial Products," Clearwater Beach, FL, 1986.

317.        Szentivanyi, A:  Lymphoid cell receptors, antibiotics, and host defenses against microorganisms.  In:  "Proceedings of Symposium on Antibiotics and Host Immunity," Siena, Italy, 1986.

318.        Szentivanyi, A:  Anti-allergic agents.  In:  "Proceedings of the Third International Conference on Immunopharmacology," Florence, Italy, 1986.

319.        Szentivanyi, A, and Szentivanyi, J:  Cellular and chemical mechanisms in virally induced human asthma.  In:  "Proceedings of International Symposium on Clinical Virology," Tampa, FL, 1986.

320.        Friedman, H, Nowotny, A, and Szentivanyi, A:  Enhanced skin allograft rejection in mice given endotoxin or nontoxic polysaccharide derivatives.  In:  "Proceedings of XIth International Congress of Transplant Society," Helsinki, Finland, 1986.

321.        Friedman, H, Klein, TW, Szentivanyi, A, and Nowotny, A:  Immunomodulation and soluble mediator induction by bacterial endotoxin and nontoxic polysaccharide derivatives.  In:  "Proceedings of International Symposium on Immunomodulation," Copanello, Italy, 1986.

322.        Nowotny, A, Friedman, H, Klein, TW, Newton, C, Blanchand, DK, and Szentivanyi, A:  Immunomodulatory properties of nontoxic lipopolysaccharide derivatives of endotoxin:  stimulation of immune response and mediators of immunity in vitro.  In:  "Proceedings of International Symposium on Immunological Adjuvants and Modulators of Non-specific Resistance to Microbial Infections," Office of Naval Research, Army Medical Research and Development Command and Air Force Office of Scientific Research, Columbia, MD, 1986, pp. 9-10.

323.        Friedman, H, Nowotny, A, Klein, TW, and Szentivanyi, A:  Leukemia virus-induced immunosuppression and reversal by endotoxins and nontoxic polysaccharide derivatives.  In:  "Proceedings of the XIVth International Cancer Congress," Budapest, Hungary, 1986.

324.        Szentivanyi, A, and Hackney, JF:  Pharmacologic mechanisms of drug resistance in cancer.  In:  "Proceedings of the XIVth International Cancer Congress," Budapest, Hungary, 1986.

325.        Blanchard, DK, Djeu, JY, Klein, TW, Stewart II, W, Friedman, H, and Szentivanyi, A:  Lipopolysaccharide induced gamma interferon production modulated by interleukin 2.  In:  "Proceedings of IInd International Congress on Inflammation," Monte Carlo, Monaco, 1986.

326.        Butler, RC, Friedman, H, Klein, TW, Szentivanyi, A, and Nowotny, A:  Immunomodulation by bacterial products - role of intermediary soluble factors.  In:  "Proceedings of International Symposium on Immunomodulation," Copanello, Italy, 1986.

327.        Duncan, RA, Krzanowski, JJ, Davis, JS, Polson, JB, Coffey, RG, Shimoda, T, and Szentivanyi, A:  Polyphosphoinositide metabolism in canine tracheal smooth muscle in response to a cholinergic stimulus.  Biochem. Pharmacol. 36:307, 1987.

328.        Szentivanyi, A, Friedman, H, Gillissen, G, and Szentivanyi, J:  Immunomodulatory Effects of Some Antibiotic-Induced Changes in Bacterial and Host Determinants.  In:  "Antibiosis and Host Immunity," A. Szentivanyi, H. Friedman, and G. Gillissen, eds., Plenum Press, New York, NY, 1987, pp. 3-11.

329.        Duncan, R, Krzanowski, JJ, Davis, J, Polson, JB, Coffey, R, Shimoda, T, and Szentivanyi, A:  The kinetics of the acetylcholine induced inositol phosphate formation in isolated contracting canine tracheal smooth muscle.  J. Allergy Clin. Immunol. 79:196, 1987.

330.        Robicsek, S, Polson, JB, Krzanowski, JJ, Lockey, RF, and Szentivanyi, A:  Study of human lymphocyte phosphodiesterase using high pressure liquid chromatography.  J. Allergy Clin. Immunol. 79:168, 1987.

331.        Friedman, H, Szentivanyi, A, Klein, TW, and Warren, G:  The role of cytokines in antibiotic mediated microbicidal activity.  In:  "Proceedings of Third International Symposium on the Influence of Antibiotics on the Host-Parasite Relationship," Cologne, West Germany, 1987, Abstract No. 43.

332.        Szentivanyi, A, and Szentivanyi, J:  Immune-neuroendocrine circuits in antibiotic-bacterial interactions.  In:  "Proceedings of Third International Symposium on the Influence of Antibiotics on the Host-Parasite Relationship," Cologne, West Germany, 1987, Abstract No. 40.

333.        Krzanowski, JJ, Urdaneta-Bohorquez, A, Polson, JB, Sakamoto, Y, and Szentivanyi, A:  Effects of adenosine and theophylline on canine tracheal smooth muscle tone.  Arch. Int. Pharmacodyn. Therap. 287:224, 1987.

334.        Krzanowski, JJ, Duncan, RA, Davis, JS, Polson, JB, Watanabe, T, Lockey, RF, and Szentivanyi, A:  The formation of inositol 1,2,3,5, tetrakisphosphate (IP4) in isolated contracting canine tracheal smooth muscle.  In:  "Proceedings of Xth International Congress of Pharmacology," Sidney, Australia, 1987, Abstract No. 01.

335.        Nowotny, A, Blanchard, K, Newton, C, Klein, TW, Stewart II, W, Szentivanyi, A, and Friedman, H:  Interferon induction by endotoxin-derived nontoxic polysaccharides.  J. Interferon Res.  7:371, 1987.

336.        Polson, JB, Lockey, RF, Bukantz, SC, Lowitt, S, Krzanowski, JJ, and Szentivanyi, A:  Effects of ketotifen on the responsiveness of human peripheral blood lymphocyte beta adrenergic receptors.  The Pharmacologist 29:132, 1987.

337.        Duncan, RA, Krzanowski, JJ, Davis, J, Coffey, RG, Polson, JB, Watanabe, T, and Szentivanyi, A:  The dose-response relationship between inositol phosphate formation and contractile responses in canine tracheal smooth muscle.  The Pharmacologist 29:117, 1987.

338.        Szentivanyi, A:  The normal physiologic significance of the pharmacologic effector systems in the pathology of asthma.  In:  "Proceedings of Symposium on the Immunopathology of Bronchial Asthma, XII World Congress of Asthmology," Barcelona, Spain, 1987, Abstract No. 6, p. 18.

339.        Schwartz, ME, Heim, O, Szentivanyi, A, and Filipp, G:  The effects of isoproterenol, forskolin, pertussis and cholera toxins on N-formyl-methionyl-leucyl-phenylalanine triggered respiratory burst in human neutrophils derived from normal and asthmatic individuals.  In:  "Proceedings of XII World Congress of Asthmology," Barcelona, Spain, 1987, Poster Presentation No. 19, p. 45.

340.        Szentivanyi, A:  Bifurcation of the inositol-lipid signal pathway and the constitutional basis of atopic disease.  In:  "Proceedings of Workshop No. 5 on Non-Reaginic Mechanisms in Asthma, XII World Congress of Asthmology," Barcelona, Spain, 1987, Abstract No. 9, p. 24.

341.        Szentivanyi, A, Reiner, S, Filipp, G, and Heim, O:  The influence of anterior hypothalamic lesions on the kinetic parameters of 125I-VIP (vasoactive intestinal peptide) binding to murine mononuclear cells.  In:  "Proceedings of Workshop No. 12 on Mediators in Asthma, XII World Congress of Asthmology," Barcelona, Spain, 1987, Abstract No. 10, p. 41.

342.        Szentivanyi, A, Krzanowski, JJ, and Polson, JB:  The Autonomic Nervous System and Altered Effector Responses.  In:  "Allergy - Principles and Practice," E. Middleton, C.E. Reed, and E.F. Ellis, eds., Third Edition, The C.V. Mosby Co., St. Louis, MO, 1988, pp. 461-493.

343.        Robicsek, S, Polson, JB, Krzanowski, JJ, Lockey, RF, and Szentivanyi, A:  High pressure liquid chromatography of human T-lymphocyte phosphodiesterases.  Clin. Pharmacol. Therap. 43:167, 1988.

344.        Polson, JB, Lockey, RF, Bukantz, SC, Lowitt, S, Krzanowski, JJ, and Szentivanyi, A:  Responsiveness of lymphocyte beta adrenergic receptors in patients treated with ketotifen.  Clin. Pharmacol. Therap. 43:137, 1988.

345.        Szentivanyi, A, Szentivanyi, J, Haberman, K, and Heim, O:  Nonantibiotic properties of antibiotics in relationship to immune-neuroendocrine influences.  Clin. Pharmacol. Therap. 43:166, 1988.

346.        Szentivanyi, A:  Plenary Lecture:  Natural neuropeptides in the immunologic inflammation of the airways in asthma.  In:  "Proceedings of the XIVth World Congress of Natural Medicines," Benalmadena-Costa, Malaga, Spain, 1988.

347.        Szentivanyi, A, Haberman, K, Heim, O, Schultze, P, Filipp, G, and Reiner, S:  Hypothalamic and other central influences on antibiosis and host immunity.  In:  "Proceedings of Fourth International Conference on Immunopharmacology," Osaka, Japan, 1988, Abstract No. 5101.

348.        Szentivanyi, A, Reiner, S, Heim, O, Filipp, G, and Abarca, CM:  Some biochemical and cellular features of adrenergic mechanisms induced by bacterial lipopolysaccharide endotoxin in rats with or without chemical sympathetic ablation (axotomy) achieved by 6-hydroxydopamine hydrobromide (6-OHDA).  In:  "Proceedings of International Symposium on Endotoxin," Jichi Medical School, Tochigi, Japan, 1988, Abstract No. SV-8.

349.        Szentivanyi, A:  The discovery of immune-neuroendocrine circuits and the concepts of prevailing immunologic thought that impeded the timely recognition of their role in immune-homeostasis.  In:  "Proceedings of the International Symposium on Interactions Between the Neuroendocrine and Immune Systems," Montepaone Lido, Italy, 1988, Abstract No. L-1, pp. 23-24.

350.        Polson, JB, Lockey, RF, Bukantz, SC, Lowitt, S, Krzanowski, JJ, and Szentivanyi, A:  Effects of ketotifen on the responsiveness of peripheral blood lymphocyte beta adrenergic receptors.  Int. J. Immunopharmacol. 10(6):657-663, 1988.

351.        Szentivanyi, A, Reiner, S, Heim, O, Filipp, G, and Abarca, CM:  The effect of 6-hydroxydopamine hydrobromide (6-OHDA) on endotoxin induced adrenergic mechanisms.  In:  "Proceedings of Second International Meeting on Respiratory Allergy," Sorrento, Italy, 1988, Abstract No. 311.

352.        Szentivanyi, J, Szentivanyi, A, Schultze, P, Filipp, G, and Heim, O: Influences of hypothalamic and extrahypothalamic brain structures on the immunogenicity of antibiotic-pretreated bacteria.  In:  Proceedings of 1988 Annual Meeting of the International Society for Interferon Research," Kyoto, Japan, 1988, Abstract No. 5-30.

353.        Schwartz, ME, Reiner, S, Heim, O, Abarca, C, and Szentivanyi, A:  Further observations on the cellular and molecular mechanisms involved in the reciprocal histamine-catecholamine counterregulatory interplay in relation to induction of histidine decarboxylase synthesis by interleukin-3 and granulocyte-macrophage colony stimulating factor.  In:  "Proceedings of XIII International Congress of Allergology and Clinical Immunology," Montreux, Switzerland, 1988, Abstract No. 64.

354.        Friedman, H, Szentivanyi, A, Klein, T, and Warren, G:  The role of lymphokines, monokines, and other effector molecules in antibiotic mediated microbial activity.  In:  "Proceedings of XIII International Congress of Allergology and Clinical Immunology," Montreux, Switzerland, 1988, Abstract No. 985.

355.        Szentivanyi, A, and Szentivanyi, J:  Antibiotic-bacterial interactions in relation to immune-neuroendocrine circuits.  In:  "Proceedings of XIII International Congress of Allergology and Clinical Immunology," Montreux, Switzerland, 1988, Abstract 986.

356.        Robicsek, S, Polson, JB, Krzanowski, JJ, Lockey, RF, and Szentivanyi, A:  Separation of lymphocyte cyclic nucleotide phosphodiesterases by ion exchange high pressure liquid chromatography. Adv. Second Messenger and Phosphoprotein Res. 21A:24, 1988.

357.        Szentivanyi, A:  Molecular Mechanisms Involved in the Develeopment of Drug Tolerance to Beta2 Adrenergic Agents.  In:  "Biochemical Determinants of Chemosensitivity to Drugs," R.D. Magee and J. O'Connel, eds., Millenium Medicine Press, Dublin, Ireland, 1989, pp. 126-134.

358.        Szentivanyi, A:  The Endogenous Opioid Peptides - A Growing Family of Immunologically Pertinent Substances.  In:  "Intrinsic Pain Mechanisms," B. Connolly and S.F. Branson, eds., Millenium Medicine Press, Dublin, Ireland, 1989, pp. 212-220.

359.        Friedman, H, Szentivanyi, A, Klein, TW, and Warren, G:  Ampicillin or Cyclacillin Pretreatment of E. coli Enhances Antibody Mediated Complement-Dependent Bacteriolysis, Phagocytosis, Blastogenesis, and Production of Interleukin 1, Interferons, and Tumor Necrosis Factor.  In:  "The Influence of Antibiotics on the Host-Parasite Relationship III," G. Gillissen, W. Opferkuch, G. Peters, and G. Pulverer, eds., Springer-Verlag, Heidelberg, Federal Republic of Germany, 1989, pp. 263-273.

360.        Szentivanyi, J, Szentivanyi, A, Schultze, P, Filipp, G, and Heim, O:  Changes in the Immune Parameters of Antibiotic-Bacterial Interactions Induced by Hypothalamic and Other Electrolytic Brain Lesions Produced Through Stereotaxically Implanted Depth Electrodes.  In:  "The Influence of Antibiotics on the Host-Parasite Relationship III," G. Gillissen, W. Opferkuch, G. Peters, and G. Pulverer, eds., Springer-Verlag, Heidelberg, Federal Republic of Germany, 1989, pp. 237-244.

361.        Robicsek, S, Krzanowski, JJ, Szentivanyi, A, and Polson, JB:  Analysis of human T-lymphocyte cyclic nucleotide phosphodiesterase activity by high pressure liquid chromatography and type III inhibitors.  FASEB J. 3:1295, 1989.

362.        Szentivanyi, A, Reiner, S, Heim, O, Filipp, G, and Abarca, C.:  The effect of sympathetic ablation [6-hydroxydopamine hydrobromide (6-OHDA); axotomy] on endotoxin induced adrenergic mechanisms.  The Pharmacologist 31:118, 1989.

363.        Szentivanyi, J, Schultze, P, Heim, O, Abarca, C, and Szentivanyi, A:  Hypothalamic and other central influences on antibiotic modulated bacterial immunogenicity.  The Pharmacologist 31:193, 1989.

364.        Szentivanyi, A:  The Discovery of Immune-Neuroendocrine Circuits in the Fall of 1951.  In:   "Interactions Among the Central Nervous System, Neuroendocrine and Immune Systems," J.W. Hadden, G. Nistico, and K. Masek, eds., Pythagora Press, Rome, Italy, 1989, pp. 1-5.

365.        Robicsek, S, Krzanowski, JJ, Szentivanyi, A, and Polson, JB:  High pressure liquid chromatography of cyclic nucleotide phosphodiesterase from purified human T-lymphocytes.  Biochem. Biophys. Res. Comm. 163:554, 1989.

366.        Szentivanyi, A:  The nature of reciprocal adrenoceptor subtype display following endotoxin (LPS) exposure.  Acta. Biomed. Hung. Amer. 1:11, 1989.

367.        Krzanowski, JJ, Schwartz, ME, Reiner, S, Heim, O, Abarca, C, and Szentivanyi, A:  Adrenergic influences on the induction of histidine decarboxylase synthesis in hematopoietic progenitor cells.  J. Leukocyte Biol. 46:294, 1989.

368.        Szentivanyi, A, Reiner, S, Heim, O, Filipp, G, and Abarca, C:  In vivo and in vitro studies on adrenergic mechanisms induced by Escherichia coli endotoxin.  J. Leukocyte Biol. 46:328, 1989.

369.        Szentivanyi, A, Schwartz, ME, Heim, O, Filipp, G, and Abarca, C:  Ketotifen treatment restores the beta adrenergic modulation of the N-formylmethionyl-leucyl-phenylalanine (FMLP) induced respiratory burst in polymorphonuclear leukocytes (PMN) in asthma.  J. Clin. Pharmacol. 29:859, 1989.

370.        Szentivanyi, J, Schultze, P, Heim, O, Reiner, S, Robicsek, S, Abarca, C, and Szentivanyi, A:  The effect of hypothalamic and extrahypothalamic nuclear groupings on the antibiotic modulated bacterial immunogenicity and production of IL-1, IFN and TNF.  Cytokine 1:364, 1989.

371.        Szentivanyi, A, Schwartz, ME, Reiner, S, Heim, O, Abarca, C, Robicsek, S, and Krzanowski, JJ:  Requirements for central and peripheral adrenergic input in the induction of histidine decarboxylase synthesis by interleukin 3 (IL-3) and granulocyte-macrophage colony stimulating factor (GM-CSF) in hematopoietic progenitor cells.  Cytokine 1:133, 1989.

372.        Szentivanyi, A, Reiner, S, Schwartz, ME, Heim, O, Szentivanyi, J, and Robicsek, S:  Restoration of normal beta adrenoceptor concentrations in A549 lung adenocarcinoma cells by leukocyte protein factors and recombinant interleukin-1a (IL-1a).  Cytokine 1:118, 1989.

373.        Polson, JB, Robicsek, S, Krzanowski, JJ, and Szentivanyi, A:  Cyclic AMP phosphodiesterases in human T-lymphocytes.  In:  "Proceedings of NIH Symposium on Purine Nucleosides and Nucleotides in Cell Signalling:  Targets for New Drugs," Dialog in Science Ltd., London, England, 1989, p. C6.

374.        Robicsek, S, Krzanowski, JJ, Polson, JB, and Szentivanyi, A:  Reevaluation of theophylline for asthma?  J. Clin. Pharmacol. 29:859, 1989.

375.        Robicsek, S, Krzanowski, JJ, Polson, JB, and Szentivanyi, A:  Inhibition of cyclic AMP-phosphodiesterases and the mechanism of action of theophylline in bronchial asthma.  In:  "Proceedings of the Annual Meeting of the Southeastern Pharmacology Society," Augusta, GA, 1989.

376.        Kunkel, G, Paus, R, Polson, JB, and Szentivanyi, A:  Beta-adrenergic receptors in nasal tissue with reference to their role in asthma and atopy.  Allergol. et Immumopathol. 17:67, 1989.

377.        Polson, JB, Robicsek, S, Krzanowski, JJ, and Szentivanyi, A:  Particulate cyclic AMP phosphodiesterase in human T-lymphocytes.  Clin. Pharmacol. Therap. 47(2):169, 1990.

378.        Szentivanyi, A, Schwartz, ME, Heim, O, and Filipp, G:  Ketotifen and the N-formylmethionyl-leucyl-phenylalanine (FMLP) induced respiratory burst in asthma.  Clin. Pharmacol. Therap. 47(2):137, 1990.

379.        Szentivanyi, A, Krzanowski, JJ, Polson, JB, and Abarca, CM:  The pharmacology of microbial modulation in the induction and expression of immune reactivities. I. The pharmacologically active effector molecules of immunologic inflammation, immunity, and hypersensitivity.  Immunopharmacology Rev. 1:159, 1990.

380.        Robicsek, S, Blanchard, DK, Djeu, J, Krzanowski, JJ, Szentivanyi, A, and Polson, JB:  Attenuation of human T-lymphocyte blastogenesis by the selective inhibition of cAMP-phosphodiesterases.  FASEB J. 4(3):A337 Abstract No. 410, 1990.

381.        Robicsek, S, Blanchard, DK, Djeu, J, Krzanowski, JJ, Szentivanyi, A, and Polson, JB:  Synergistic effect on T-lymphocyte blastogenesis by selective cAMP-phosphodiesterase inhibitors.  FASEB J. 4:2036, 1990.

382.        Szentivanyi, A, Schwartz, ME, Heim, O, Filipp, G, and Abarca, C.:  Ketotifen and the n-formylmethionyl-leucyl-phenylalanine (FMLP) induced respiratory burst in asthma.  J. Clin. Pharmacol. 30:92, 1990.

383.        Szentivanyi, A, Reiner, S, Heim, O, Abarca, C, Szentivanyi, J, Robicsek, S, and Hackney, J:  Impaired lymphokine regulation of ß-adrenoceptors in asthma and atopic dermatitis.  J. Leukocyte Biol., Suppl. 1:183, 1990.

384.        Hackney, JF, Szentivanyi, A, Reiner, S, Schwartz, ME, Heim, O, Szentivanyi, J, and Abarca, C:  Immunoneutralization studies of the nature of the ß-adrenoceptor upregulating effect of lymphocyte conditioned medium of IM9 cells on A549 lung cells.  J. Leukocyte Biol., Suppl 1:68, 1990.

385.        Robicsek, S, Blanchard, DK, Djeu, J, Krzanowski, JJ, Polson, JB, and Szentivanyi, A:  Multiple cyclic nucleotide phosphodiesterase activities and the selective modulation of function in human T-lymphocytes.  J. Leukocyte Biol., Suppl. 1: 232, 1990.

386.        Szentivanyi, A, Schultze, P, Heim, O, Reiner, S, Robicsek, S, Zority, J, Hackney, JF, and Lockey, RF:  Resolution of the ß-adrenoceptor regulating activity in A549 lung cells of lymphocyte conditioned medium derived from cultured IM9 cells with DEAE ion exchange HPLC.  J. Allergy Clin.Immunol. 87:158, 1991.

387.        Hackney, JF, Heim, O, Schultze, P, Wagner, H, Zority, J, Lockey, RF, Krzanowski, JJ, and Szentivanyi, A:  Adrenergic mechanisms on the IL-3 and GM-CSF induced de novo synthesis of histidinedecarboxylase in hemopoietic progenitor cells.  J. Allergy Clin. Immunol. 87:285, 1991.

388.        Robicsek, S, Heim, O, Reiner, O, Hackney, JF, Zority, J, Lockey, RF, and Szentivanyi, A:  Characterization of the A549 ß-adrenoceptor regulating protein components of lymphocyte conditioned medium of IM9 cells.  J. Allergy Clin. Immunol. 87:307, 1991.

389.        Szentivanyi, A, Reiner, S, Heim, O, Robicsek, S and Hackney, JF:  Studies on the nature of the lymphocytic protein factors upregulating beta-adrenergic receptors.  Clin. Pharmacol. Therap. 149:139, 1991.

390.        Szentivanyi, A:  Beta-adrenergic subsensitivity in asthma and atopic dermatitis:  A status report.  Acta. Biomed. Hung. Amer. 1, 1991.

391.        Robicsek, S, Heim, O, Reiner, S, Zority, J, Hackney, JF, Lockey, RF, Calderón, EG, and Szentivanyi, A:  The nature of the pharmacologically active constitutents of lymphocyte conditioned medium of IM9 cells regulating the beta-adrenergic receptors of A549 cells.  In:  "Proceedings of 4th Interscience World Conference on Inflammation," Bioscience Ediprint, Geneva, Switzerland, 1991, Abstract 143.

392.        Szentivanyi, A, Heim, O, Schultze, P, Wagner, H, Zority, J, Calderón, E, and Lockey, RF: Sensitization of bone marrow hemopoietic progenitor cells to the interleukin-3 and granulocyte-macrophage colony stimulating factor induced de novo synthesis of histidine decarboxylase through the activtion of beta-adrenergic receptors.  In:  "Proceedings of 4th Interscience World Conference on Inflammation," Bioscience Ediprint, Geneva, Switzerland, 1991, Abstract 146.

393.        Szentivanyi, J, Reiner, S, Heim, O, Zority, J, Robicsek, S, Lockey, RF, Calderón, E, and Szentivanyi, A:  Lymphocyte conditioned medium derived from peripheral blood lymphocytes of patients with asthma or atopic dermatitis shows a reduced capacity to regulate beta adrenergic receptors of A549 lung cells.  In:  "Proceedings of 4th Interscience World Conference on Inflammation," Bioscience Ediprint, Geneva, Switzerland, 1991, Abstract 144.

394.        Szentivanyi, A, Schultze, P, Heim, O, Reiner, S, Robicsek, S, Zority, J, Hurt, KJ, Hackney, JF, Calderón, EG, and Lockey, RF:  The elution profile of the A549 beta adrenergic regulating activity of lymphocyte conditioned medium of IM9 cells developed by DEAE ion exchange HPLC.  In:  "Proceedings of 4th Interscience World Conference on Inflammation," Bioscience Ediprint, Geneva, Switzerland, 1991, Abstract 145.

395.        Calderón, EG, Heim, O, Schultze, P, Wagner, H, Zority, J, Lockey, RF, and Szentivanyi, A: Concentrations of adrenergic and histamine receptors on murine bone marrow cells fractionated on a discontinuous Ficoll gradient.  In:  "Proceedings of the 4th Interscience World Conference on Inflammation," Bioscience Ediprint, Geneva, Switzerland, 1991, Abstract 332.

396.        Szentivanyi, A:  Effect of hypothalamic influences on the immunopharmacology of antibacterial resistance.  In:  "Proceedings of International Symposium on Microbial Infections:  Role of Biological Response Modifiers," Clearwater Beach, FL, 1991.

397.        Szentivanyi, A, Schultze, M, Heim, O, Reiner, S, Robicsek, S, Zority, J, Hackney, JF, Hurt, K, Calderón, EG and Lockey, RF:  Characterization of lymphocytic proteins with beta-adrenergic activity in lung cells.  Europ. Resp. J. 4:307, 1991.

398.        Szentivanyi, A, Schultze, M, Heim, O, Reiner, S, Robicsek, S, Zority, J, Hackney, JF, Hurt, K, Calderón, EG, and Lockey, RF:  Lymphokine effects involved in adrenergic dysregulation in asthma and cystic fibrosis.  Europ. Resp. J. 4:460, 1991.

399.        Robicsek, S, Blanchard, DK, Djeu, JY, Krzanowski, JJ, Szentivanyi, A and Polson, JB:  Multiple high affinity cAMP-phosphodiesterases regulate proliferation in human thymic lymphocytes.  Biochem. Pharmacol. 42(4):869-877, 1991.

400.        Szentivanyi, A, Schultze, P, Heim, O, Reiner, S, Robicsek, S, Zority, J, Hackney, JF, Hurt, K, Calderón, EG, and Lockey, RF:  Lymphokine effects involved in adrenergic dysregulation in asthma and cystic fibrosis.  In:  "Proceedings of the First Annual Congress of the European Respiratory Society," Brussels, Belgium, 1991, Abstract 1371.

401.        Szentivanyi, A, Schultze, P, Heim, O, Reiner, S, Robicsek, S, Zority, J, Hackney, JF, Hurt, K, Calderón, EG, and Lockey, RF:  Characterization of lymphocytic proteins with beta-adrenergic activity in lung cells.  In:  "Proceedings of the First Annual Congress of the European Respiratory Society," Brussels, Belgium, 1991, Abstract 1372.

402.        Szentivanyi, A, Calderón, EG, Heim, O, Schultze, P, Wagner, H, Zority, J, Lockey, RF, Dwornik, JJ, and Robicsek, S:  Adrenergic and histamine receptors in bone marrow cells.  In:  "Proceedings of the XIV International Congress of Allergology and Clinical Immunology," Kyoto, Japan, 1991, Abstract No. 0281.

403.        Szentivanyi, A, Schultze, P, Heim, O, Reiner, S, Robicsek, S, and Lockey, RF:  Separation of lymphocytic proteins with beta-adrenergic regulating activity.  In:  "Proceedings of the XIV International Congress of Allergology and Clinical Immunology," Kyoto, Japan, 1991, Abstract No. 0255.

404.        Szentivanyi, A, Reiner, S, Heim, O, Hackney, JF, Robicsek, S, Lockey, RF, Dwornik, JJ, and Szentivanyi, J:  Impaired lymphokine regulation of beta-adrenoceptors in atopy.  In:  "Proceedings of the XIV International Congress of Allergology and Clinical Immunology," Kyoto, Japan, 1991, Abstract No. 0340.

405.        Szentivanyi, A, Heim, O, Schultze, P, Wagner, H, Zority, J, Calderón, E, Dwornik, JJ, and Lockey, RF:  Beta-adrenergic, IL-3 and GM-CSF interplay on bone marrow cells in the induction of histidine decarboxylase.  In:  "Proceedings of the XIV International Congress of Allergology and Clinical Immunology," Kyoto, Japan, 1991, Abstract No. 1089.

406.        Szentivanyi, A, Robicsek, S, Heim, O, Reiner, S, Zority, J, Hackney, JF, Lockey, RF, Dwornik, JJ, and Calderón, EG:  Immunoneutralization of adrenergic activities of lymphocytic proteins.  In:  "Proceedings of the XIV International Congress of Allergology and Clinical Immunology," Kyoto, Japan, 1991, Abstract No. 0791.

407.        Szentivanyi, A, Schultze, P, Heim, O, Reiner, S, Robicsek, S, Zority, J, Hurt, KJ, Hackney, JF, Calderón, EG, Dwornik, JJ, and Lockey, RF:  The elution profile of the A549 beta adrenergic (ßAR) regulating activity of lymphocyte conditioned medium (LCM) of IM9 cells developed by DEAE ion exchange HPLC.  Int. J. Immunopharmacol. 13:68, 1991.

408.        Szentivanyi, A, Calderón, EG, Heim, O, Schultze, P, Wagner, H, Zority, J, Lockey, RF, Dwornik, JJ, and Robicsek, S:  Adrenergic and histamine receptor concentrations in bone marrow cells.  Int. J. Immunopharmacol. 13:740, 1991.

409.        Szentivanyi, A, Robicsek, S, Heim, O, Reiner, S, Zority, J, Hackney, JF, Lockey, RF, Dwornik, JJ, and Calderón, EG:  The nature of the adrenergically active constituents of lymphocyte conditioned medium (LCM) of IM9 cells.  Int. J. Immunopharmacol. 13:70, 1991.

410.        Szentivanyi, A, Heim, O, Schultze, P, Wagner, H, Zority, J, Calderón, E, Dwornik, JJ, and Lockey, RF:  Sensitization of bone marrow hemopoietic progenitor cells to the interleukin-3 (IL-3) and granulocyte macrophage colony stimulating factor (GM-CSF) induced de novo synthesis of histidine decarboxylase through the activation of beta adrenoceptors.  Int. J. Immunopharmacol. 13:73, 1991.

411.        Szentivanyi, J, Reiner, S, Heim, O, Hackney, JF, Robicsek, S, Lockey, RF, Dwornik, JJ, and Szentivanyi, A:  Impaired capacity of lymphocyte proteins to upregulate beta-adrenoceptors in A549 human lung adenocarcinoma cells in respiratory and cutaneous atopic disease.  Int. J. Immunopharmacol.  13:743, 1991.

412.        Robicsek, S, Blanchard, DK, Djeu, J, Krzanowski, JJ, Szentivanyi, A, and Polson, JB:  Attenuation of IL-2 and Tac receptor expression by selective PDE inhibitors in human T-lymphocytes.  Int. J. Immunopharmacol.  13:734, 1991.

413.        Dwornik, JJ, Szentivanyi, A, Heim, O, Schultze, P, Wagner, H, Zority, J, Calderón, EG, and Lockey, RF:  IL-1a may replace requirement for adrenergic input in the sensitization of bone marrow hemopoietic progenitor cells to the IL-3 and GM-CSF induced de novo synthesis of histidine decarboxylase.  J. Allergy Clin. Immunol. 89:310, 1992.

414.        Szentivanyi, J, Heim, O, Schultze, P, Wagner, H, Calderón, EG, Lockey, RF, Robicsek, S, and Szentivanyi, A:  Similarities and differences in patterns of beta-adrenergic regulation by lymphocytic proteins in respiratory and cutaneous atopy versus cystic fibrosis.  J. Allergy Clin. Immunol. 89:162, 1992.

415.        Robicsek, S, Szentivanyi, A, Calderón, EG, Heim, O, Schultze, P, Wagner, H, Lockey, RF, and Dwornik, JJ:  Concentrated IL-1a derived from human T-lymphocytes binds to a specific single class surface receptor on human bronchial epithelial cells and induces the production of beta-adrenoceptor mRNA via an associated or separate receptor-linked signalling pathway.  J. Allergy Clin. Immunol. 89:212, 1992.

416.        Szentivanyi, A, Calderón, EG, Heim, O, Schultze, P, Wagner, H, Zority, J, Lockey, RF, Dwornik, JJ, and Robicsek, S:  Cell- and species-specific dissociation in the beta-adrenoceptor upregulating effects of IL-1a derived from lymphocyte conditioned medium and cortisol.  J. Allergy Clin. Immunol. 89:274, 1992.

417.        Calderón, EG, Heim, O, Szentivanyi, A, Schultze, P, Wagner, H, Zority, J, Lockey, RF, Dwornik, JJ, and Robicsek, S:  Adrenergic and histamine receptor concentrations in bone marrow cells.  J. Allergy Clin. Immunol. 89:277, 1992

418.        Szentivanyi, A, Krzanowski, JJ, Polson, JB, and Abarca, CM:  Continued studies on the molecular mechanisms of diminished beta adrenergic responsiveness in human asthma and atopic dermatitis.  In:  "Asthmology:  Immunophysiopathology, Diagnostic and Therapeutic Progress," A. Oehling and F. Munoz, eds., J.R. Prous, Barcelona, Spain, 1992.

419.        Szentivanyi, A:  Adrenergic regulation.  In:  "Bronchial Asthma - Mechanisms and Therapeutics," E.B. Weiss and M. Stein, eds., Third Edition, Little, Brown and Company, Boston, 1993, pp. 165-191.

420.        Szentivanyi, A:  The immune-neuroendocrine circuitry and its relation to asthma.  In:  "Bronchial Asthma - Mechanisms and  Therapeutics," E.B. Weiss and M. Stein, eds., Third Edition, Little, Brown and Company, Boston, 1993, pp. 421-438.

421.        Szentivanyi, A, Ali, K, Calderón, EG, Brooks, SM, Coffey, RG, and Lockey, RF.  The in vitro effect of immunoglobulin E (IgE) on cyclic AMP concentrations in A549 human pulmonary epithelial cells with or without beta-adrenergic stimulation.  J. Allergy Clin. Immunol. 91:379, 1993.

422.        Calderón, E, Gómez-Sánchez, CE, Cozza, EN, Coffey, RG, and Szentivanyi, A  Regulation of endothelin-1 production in A549 epithelial cells.  J. Immunol. 150(8):64A, 1993. Abstract # 352.

423.        Ali, K, Calderón, EG, Brooks, SM, Coffey, RG, Lockey, RF, and Szentivanyi, A  The effect of IgE on beta-adrenergic responsiveness as measured by cyclic AMP production of A549 cells.  J. Immunol. 150(8):65A, 1993.  Abstract #345.

424.        Ali, K, Calderón, EG, Brooks, SM, Coffey, RG, Lockey, RF, and Szentivanyi, A  The in vitro effect of immunoglobulin E on cyclic AMP concentrations in A549 human pulmonary epithelial cells with or without beta-adrenergic stimulation.  Am. Rev. Resp. Dis.  147(5), 1993.

425.        Ali, K, Calderón, EG, Brooks, SM, Coffey, RG, Lockey, RF, and Szentivanyi, A  The in vitro effect of immunoglobulin E on cyclic AMP concentrations in A549 human pulmonary epithelial cells with or without beta-adrenergic stimulation.  FASEB J. 7(3):A146, 1993. Abstract #845.

426.        Szentivanyi, A:  The Immune-Neuroendocrine Circuitry--A Generation of Progress.  In:  "The Immunological Revolution:  Facts and Witnesses," A. Szentivanyi and H. Friedman, eds., CRC Press, Inc., Boca Raton, FL, 1993, pp. 383-402.

427.        Stewart, GE, Calderón, E, Szentivanyi, A, and Lockey, RF:  IgE decreases endothelin-1 production in A549 pulmonary epithelial cells.  J. Allergy Clin. Immunol. 93:244, 1994.

428.        Ali, K, Rao, UR, Brooks, SM, Coffey, RG, and Szentivanyi, A:  Regulation of nitric oxide (NO) synthesis in pulmonary epithelial cells.  Amer. J. Resp. Cell Mol. Biol., 10, 1994, Abstract #272017.

429.        Ali, K, Rao, UR, Brooks, SM, Coffey, RG, Rabb, H, and Szentivanyi, A:  IgE and dexamethasone modulate the synthesis of nitric oxide (NO) in pulmonary epithelial cells.  FASEB J. 8(4):A143,1994, Abstract #828.

430.        Calderón, E, Gómez-Sánchez, CE, Cozza, EN, Coffey, RG, Lockey, RF, Prockop, LD, and Szentivanyi, A:  The in vitro immune-neuroendocrine modulation of endothelin-1 production by A549 pulmonary epithelial cells. I. Regulation by corticosteroids.  Biochem. Pharmacol. 48:2065, 1994.

431.        Szentivanyi, A and Abarca, C:  The Immune-Neuroendocrine Circuitry - The Next, and Possibly, the Last Frontier of Vertebrate Immunity.  In: "Advances in Psychoneuroimmunology," Vol. 3, I Berczi and J Szelényi, eds., Plenum Press, New York, 1994, pp. 41-74.

432.        Szentivanyi, A, Ali, K, Abarca, C, and Brooks, SM:  Environmental immunotoxicology.  In: "Environmental Medicine," SM Brooks, M Gochfeld, RJ Jackson, J Herzstein and MB Schenker, eds., Mosby-Year Book, Inc., St. Louis, MO, 1995, Part II, Chapter 12, pp. 139-155.

433.        Szentivanyi, A, Ali, K, Abarca, C, Prockop, L, and Brooks, SM:  The immunology of cancer.  In:  Environmental Medicine," SM Brooks, M Gochfeld, RJ Jackson, J Herzstein and MB Schenker, eds., Mosby-Year Book, Inc., St. Louis, MO, 1995, Part II, Chapter 13, pp. 156-165.

434.        Maccia, CA, Szentivanyi, A, Ali, K, Abarca, C, and Brooks, SM:  Disorders of the immune system.  In:  "Environmental Medicine," SM Brooks, M Gochfeld, RJ Jackson, J Herzstein and MB Schenker, eds., Mosby-Year Book, Inc., St. Louis, MO, 1995, Part III, Chapter 27, pp. 326-348.

435.        Szentivanyi, A:  The beta-adrenergic theory of the atopic abnormality in bronchial asthma. Reprinted In:  "Milestones in Allergy," L Berrens, ed., Mosby/Doyma Libros, Barcelona, Spain, 1995, pp. 69-102.

436.        Berczi, I and Szentivanyi, A:  The pituitary gland, psychoneuroimmunology and infection. In:  "Psychoneuroimmunology, Stress, and Infection," H Friedman, TW Klein, and A Friedman, eds., CRC Press, Boca Raton, FL, 1996, pp. 71-98.

437.        Szentivanyi, A,  Abarca, CM, Brooks, SM, Lockey, RF, and Prockop, LD:  Some evolutionary, morphoregulatory and functional aspects of the immune-neuroendocrine circuitry. Immunopharmacology Rev. 2:379-440, 1996.

438.        Szentivanyi, A, and Goldman, AL:  Vagotonia and bronchial asthma: an editorial.  Chest 111(1):8-11, 1997.

439.        Berczi I, Szentivanyi A. Why Neuroimmune Biolory? Editorial. In “Neuroimmune Biology Volume 1: New foundation of Biology” Berczi I, Gorczynski R, Editors, Elsevier, 2001;pp. vii-xii

440.        Szentivanyi A, Berczi I, Pitak D, Goldman A. Studies of the hypothalamic regulation of histamine synthesis. In “Neuroimmune Biology Volume 1: New foundation of Biology” I. Berczi I, Gorczynski R, Editors, Elsevier, 2001; pp. 47-55

441.        .Berczi I. Szentivanyi A. Foreword. In “Neuroimmmune Biology, Volume 3: The Immune-Neuroendocrine Circuitry. History and Progress. Berczi I, Szentivanyi A, Editors, Elsevier, Amsterdam, 2003; p. v.

442.        Berczi I. Szentivanyi A. Preface. In “Neuroimmmune Biology, Volume 3: The Immune-Neuroendocrine Circuitry. History and Progress. Berczi I, Szentivanyi A, Editors, Elsevier, Amsterdam, 2003; pp. vii-viii.

443.        Szentivanyi A, Berczi I, Nyanteh H, Goldman A. Introduction. In “Neuroimmmune Biology, Volume 3: The Immune-Neuroendocrine Circuitry. History and Progress. Berczi I, Szentivanyi A, Editors, Elsevier, Amsterdam, 2003; p.5.

444.        Szentivanyi A, Berczi I, Nyanteh H, Goldman A. history. In “Neuroimmmune Biology, Volume 3: The Immune-Neuroendocrine Circuitry. History and Progress. Berczi I, Szentivanyi A, Editors, Elsevier, Amsterdam, 2003; pp.7-14.

445.        Szentivanyi A, Berczi I, Nyanteh H, Goldman A. The discovery of immune neuroendocrine circuitry - A generation of progress. In “Neuroimmmune Biology, Volume 3: The Immune-Neuroendocrine Circuitry. History and Progress. Berczi I, Szentivanyi A, Editors, Elsevier, Amsterdam, 2003; pp. 15-18.

446.        Szentivanyi A, Berczi I, Nyanteh H, Goldman A. Altered effector responses. In “Neuroimmmune Biology, Volume 3: The Immune-Neuroendocrine Circuitry. History and Progress. Berczi I, Szentivanyi A, Editors, Elsevier, Amsterdam, 2003; pp. 21-29.

447.        Szentivanyi A, Berczi I, Nyanteh H, Goldman A. Some evolutionary morphoregulatory and functinal aspects of the immune-neuroendocrine circuitry. In “Neuroimmmune Biology, Volume 3: The Immune-Neuroendocrine Circuitry. History and Progress. Berczi I, Szentivanyi A, Editors, Elsevier, Amsterdam, 2003; pp. 31-61.

448.        Szentivanyi A, Berczi I, Nyanteh H, Goldman A. Virus associated immune and pharmacologic mechanisms in disorders of respiratory and cutaneous atopy. In “Neuroimmmune Biology, Volume 3: The Immune-Neuroendocrine Circuitry. History and Progress. Berczi I, Szentivanyi A, Editors, Elsevier, Amsterdam, 2003; pp. 63-95.

449.        Berczi I, Szentivanyi A. Adhesion molecules. In “Neuroimmmune Biology, Volume 3: The Immune-Neuroendocrine Circuitry. History and Progress. Berczi I, Szentivanyi A, Editors, Elsevier, Amsterdam, 2003; pp. 99-115.

450.        Berczi I, Szentivanyi A. Immunoglobulins. In “Neuroimmmune Biology, Volume 3: The Immune-Neuroendocrine Circuitry. History and Progress. Berczi I, Szentivanyi A, Editors, Elsevier, Amsterdam, 2003; pp. 117-127.

451.        Berczi I, Szentivanyi A. Growth and lactogenic hormones, insulin-like growth factor and insulin. In “Neuroimmmune Biology, Volume 3: The Immune-Neuroendocrine Circuitry. History and Progress. Berczi I, Szentivanyi A, Editors, Elsevier, Amsterdam, 2003; pp. 129-153.

452.        Berczi I, Szentivanyi A. The hypothalamus-pituitary-adrenal axis and opioid peptides. In “Neuroimmmune Biology”, Volume 3: The Immune-Neuroendocrine Circuitry. History and Progress. Berczi I, Szentivanyi A, Editors, Elsevier, Amsterdam, 2003; pp. 155-174.

453.        Berczi I, Szentivanyi A. The hypothalamus-pituitary-thyroid axis. In “Neuroimmmune Biology, Volume 3: The Immune-Neuroendocrine Circuitry. History and Progress. Berczi I, Szentivanyi A, Editors, Elsevier, Amsterdam, 2003; pp 175-180.

454.        Berczi I, Szentivanyi A. Nerve growth factror, leptin and neuropeptides. In “Neuroimmmune Biology, Volume 3: The Immune-Neuroendocrine Circuitry. History and Progress. Berczi I, Szentivanyi A, Editors, Elsevier, Amsterdam, 2003; pp. 181-189.

455.        Berczi I, Szentivanyi A. Cytokines and chemokines. In “Neuroimmmune Biology, Volume 3: The Immune-Neuroendocrine Circuitry. History and Progress. Berczi I, Szentivanyi A, Editors, Elsevier, Amsterdam, 2003; pp. 191-220.

456.        Berczi I, Nagy E, Baral E, Szentivanyi, A. Sterid Hormones. In “Neuroimmmune Biology, Volume 3: The Immune-Neuroendocrine Circuitry. History and Progress”. Berczi I, Szentivanyi A, Editors, Elsevier, Amsterdam, 2003; pp. 221-270.

457.        Berczi I, Szentivanyi A. Immunocompetence. In Neuroimmmune Biology, Volume 3: The Immune-Neuroendocrine Circuitry. History and Progress. Berczi I, Szentivanyi A, Editors, Elsevier, Amsterdam, 2003; pp. 281-299.

458.        Berczi I, Szentivanyi A. Antigen presentation. In Neuroimmmune Biology, Volume 3: The Immune-Neuroendocrine Circuitry. History and Progress. Berczi I, Szentivanyi A, Editors, Elsevier, Amsterdam, 2003;pp. 301-313.

459.        Berczi I, Szentivanyi A. Immune reactions. In Neuroimmmune Biology, Volume 3: The Immune-Neuroendocrine Circuitry. History and Progress. Berczi I, Szentivanyi A, Editors, Elsevier, Amsterdam, 2003; pp. 315-377.

460.        Berczi I, Szentivanyi A. The acute phase response. In Neuroimmmune Biology, Volume 3: The Immune-Neuroendocrine Circuitry. History and Progress. Berczi I, Szentivanyi A, Editors, Elsevier, Amsterdam, 2003; pp. 463-494.

461.        Berczi I, Szentivanyi A. Autoimmune disease. In Neuroimmmune Biology, Volume 3: The Immune-Neuroendocrine Circuitry. History and Progress. Berczi I, Szentivanyi A, Editors, Elsevier, Amsterdam, 2003; pp.495-536.

462.        Berczi I, Szentivanyi A. Immunodeficiency. In Neuroimmmune Biology, Volume 3: The Immune-Neuroendocrine Circuitry. History and Progress. Berczi I, Szentivanyi A, Editors, Elsevier, Amsterdam, 2003; pp.537-558.

463.        Berczi I, Szentivanyi A. The immune-neuroendocrine circuitry. In Neuroimmmune Biology, Volume 3: The Immune-Neuroendocrine Circuitry. History and Progress. Berczi I, Szentivanyi A, Editors, Elsevier, Amsterdam, 2003; pp. 561-592.

464.        Berczi I, Szentivanyi A. Concluding remarks and future directions. In The Neuroendocrine Immune Network in Ageing. Straub RH, Mocchegiani E. Editors, Neuroimmune Biology Volume 4. Berczi I, Szentivanyi A, Series editors. Elsevier, Amsterdam, 2004. Pp. 409-427.

465.        Berczi I, Szentivanyi A. Foreword. In Cytokines and the Brain. Phelps C, Korneva E. Editors, Neuroimmuine Biology, Volume 6. Berczi I, Szentivanyi A. Series editors. Elsevier, Amsterdam, 2006.

466.        Berczi I. Szentivanyi A. Preface. In The Hypothalamus-Pituitary-Adrenal Axis. DelRey A, Chrousos G, Besedovsky H. Editors, Neuroimmune Biology, Volume 7. Berczi I, Szentivanyi A. Series editors. Elsevier, Amsterdam, 2006.

467.        Berczi I, Szentivanyi A. Neuroimmune Biology. Current status and future perspectives. Proc. International Conference on Allergy, Immunology and Global Network: Insights into the next milleneum. New York, USA, April 14-17, 2001.

468.        Berczi I, Szentivanyi A. “ The Nuroimmune Regulatory Network”, Proc. Sixth International Conference of the Polish Neuroscience Society, July 16-19, 2003, Warsaw, Poland.

469.        Szentivanyi, A:  The immune-neuroendocrine circuitry in health and atopic disease.  In: "Cancun Proceedings Volume,"  Hogrefe & Huber Publishers, Gottingen, Germany, 1997

470.        Szentivanyi, A, Heim, O, Schultze, M., Wagner, H, Zority, J, Lockey, RF, Goldman, A, Krzanowski, JJ, and Polson, JB:  Effects of catecholamine and serotonin neurotoxins and exocitotoxic amino acids on enchanced histamine production induced by rGM-CSF and/or rIL-3. In:  "Cancun Proceedings Volume," Hogrefe & Huber Publishers, Gottingen, Germany, 1997, Abstract 1034

471.        Szentivanyi, J, Szentivanyi, A, Ali, K, Coffey, RG, Lockey, RF, Goldman, AL, Krzanowski, JJ, Polson, JB, and Friedman, H:  The effect of cytokines on the immunoglobulin E (IgE) produced reduction in nitric oxide (NO) synthesis.  Clin. Pharmacol. Therapeutics, 1998, Abstract,

472.        Robicsek, SA, Blanchard, DK, Szentivanyi, A, and Polson, JB:  Attentuation of IL-2 and IL-2 receptor expression of selective PDE inhibitors in human T-lymphocytes. (manuscript).

473.        Ali, K, Brooks, SM, Coffey, R, Lockey, RF, Abarca, CM, and Szentivanyi, A.:  Inhibition of cyclic AMP accumulation in A549 human pulmonary epithelial cells by immunoglobulin E (IgE). (manuscript)

474.        Szentivanyi, A, Abarca, CM, and Lockey, RF:  The immune-neuroendocrine circuitry as the chemical and cellular basis of immune homeostasis in health and disease. I. Component parts and control mechanisms.  (manuscript).

475.        Szentivanyi, A,  Szentivanyi, J, Abarca, CM, Brooks, SM, Lockey, RF, and Prockop, LD:  The immune-neuroendocrine circuitry as the chemical and cellular basis of immune homeostasis in health and disease. II. Implications to immunologically and/or non-immunologically based atopic disorders. (manuscript)

 

  Books  

1,         Szentivanyi, A, and Filipp, G:  Allergie und Asthma.  Johann Ambrosius Barth Verlag, Leipzig, East Germany, 1956.

2.                  Szentivanyi, A, and Filipp, G:  Immunopathologie und Immunopharmakologie der allergischen Entzundung, Kochem Verlag, Munchen, West Germany, 1959.

3.                  Szentivanyi, A, and Filipp, G:  Propriètès Immuno-Chimiques et Physico-Chimiques des Anticorps, Editions Mèdicales Flammarion, Paris, France, 1962.

4.                  Filipp, G, and Szentivanyi, A (eds.):  Pathogenese und Therapie Allergischer Reaktionen. Grundlagenforschung und Klinik. Ferdinand Enke Verlag, Stuttgart, West Germany, 1966.

5.                  Friedman, H, Klein, TW, and Szentivanyi, A, (eds.):  Immunomodulation by Bacteria and Their Products.  Plenum Press, New York and London, 1981.

6.                  Klein, TW, Specter, S, Friedman, H, and Szentivanyi, A (eds.):  Biological Response Modifiers in Human Oncology and Immunology.  Plenum Press, New York and London, 1983.

7.                  Hadden, JW, and Szentivanyi, A (eds.):  The Pharmacology of the Reticuloendothelial System.  Plenum Press, New York and London,

8.                  Szentivanyi, A, and Friedman, H (eds.):  Viruses, Immunity, and Immunodeficiency.  Plenum Press, New York and London, 1986.

9.                  Szentivanyi, A, Friedman, H, and Nowotny, A (eds.):  The Immunobiology and Immunopharmacology of Bacterial Endotoxins. Basic and Clinical Aspects.  Plenum Press, New York and London, 1986.

10.              Cory, JG, and Szentivanyi, A (eds.).:  Cancer Biology and Therapeutics.  Plenum Press, New York and London, 1987.

11.              Szentivanyi, A, Maurer, P, and Janicki, BW (eds.):  Antibodies:  Structure, Synthesis, Function, and Immunologic Intervention in Disease.  Plenum Press, New York and London, 1987.

12.              Szentivanyi, A, Gillissen, G, and Friedman, H (eds.):  Antibiosis and Host Immunity.  Plenum Press, New York and London, 1987.

13.              Hadden, JW, and Szentivanyi, A (eds.):  Immunopharmacology Reviews, Volume 1.  Plenum Press, New York and London, 1990.

14.              Szentivanyi, A, and Friedman, H (eds.):  The Immunologic Revolution:  Facts and Witnesses.  CRC Press, Inc., Boca Raton, FL, 1994.

15.              Hadden, JW, and Szentivanyi, A (eds.):  Basic and Applied Immunopharmacology.  Plenum Press, New York, NY, 1995.

16.              Berczi I, Szentivanyi A, Series Editors. Neuroimmune Biology. A serial publication of books initiated in 2001. Elsevier Publisher, Amsterdam. (www.elsevier.com/locate/nib)

17.              Berczi I, Szentivanyi A, Series editors, Berczi I, Gorczynski R, Editors: Neuroimmune Biology Volume 1; New Foundation of Biology. Elsevier, Amsterdam, 2001.

18.              Berczi I, Szentivanyi A, Series Editors, Matera L, Rapaport R, Editors, Neuroimmune Biology Volume 2: Growth and Lactogenic Hormones. Elsevier, Amsterdam, 2002.

19.              Berczi I. Szentivanyi A. Series Editors and Editors, Neuroimmmune Biology, Volume 3: The Immune-Neuroendocrine Circuitry. History and Progress. Elsevier, Amsterdam, 2003

20.              Berczi I, Szentivanyi A, Series editors, Straub RH, Mocchegiani E. Editors: Neuroimmune Biology Volume 4; The Neuroendocrine Immune Network in Ageing. Elsevier, Amsterdam, 2004.

21.              Berczi I, Szentivanyi A. Series Ed.: Phelps C, Korneva E. Editors, Cytokines and the Brain, Neuroimmuine Biology, Volume 6.. Elsevier, Amsterdam, 2006.

22.              Berczi I, Szentivanyi A. Series Ed. Del Rey A, Chrousos G, Besedovsky H. Eds: The hypothalamus-Pituitary-Adrenal Axis. Neuroimmuine Biology, Volume 7. Elsevier, Amsterdam.

23.              Berczi I, Szentivanyi A. Series Ed. Jancso G. Ed. Neurogenic inflammation. Neuroimmuine Biology, Volume 8. Elsevier, Amsterdam.

24.              Berczi I, Szentivanyi A. Series ED. Buckingham J, Arnason B, Berczi I. Eds. The Brain and Hot Defence. Neuroimmuine Biology, Volume 9.

 


Dr Andor Szentivanyi was buried Sunday Oct. 23, 2005 at Gan Shalom Cemetery, Tampa Florida. USA. 

Andor Szentivanyi was a good friend and colleague.

He will be much missed.

Goodbye 

Dear Friend.

Job Well Done

May He Rest in Peace

Any  questions, comments or problems with the website, please contact the webmaster.
email.gif
e:mail: berczii@Ms.UManitoba.CA
Copyright © 2010 berczii

Background music: Air on the g string by: JS Bach
EWS Website Designs